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ABSTRACT 
 
The purpose of this manuscript is to discuss fluorogenic real-time quantitative polymerase chain reaction (qPCR) 
inhibition and to introduce/define a novel Microsoft Excel-based file system which provides a way to detect and avoid 
inhibition, and enables investigators to consistently design dynamically-sound, truly LOG-linear qPCR reactions very 
quickly. The qPCR problems this invention solves are universal to all qPCR reactions, and it performs all necessary 
qPCR set-up calculations in about 52 seconds (using a pentium 4 processor) for up to seven qPCR targets and seventy-
two samples at a time – calculations that commonly take capable investigators days to finish. We have named this 
custom Excel-based file system “FocusField2-6GallupqPCRSet-upTool-001” (FF2-6-001 qPCR set-up tool), and are in 
the process of transforming it into professional qPCR set-up software to be made available in 2007. The current 
prototype is already fully functional. 
 
PREFACE 
 
Bearing in mind that it is not possible to state with 
absolute certainty the exact causes of qPCR inhibitory 
phenomena, and since more than one kind of inhibition 
may be present at the same time, we begin this 
communication by creating a list of the top five most 
likely sources of such inhibition – two of which 
(inhibition Types 2 and 3) are inherently a function of 
one another. We propose that all five affect either the 
activity of reverse transcriptase enzymes, Taq DNA 
polymerases, or both. In order to avoid using sample 
RNA (or cDNA) at dilutions permissive of or conducive 
to real-time qPCR inhibitory phenomena (regardless of 
the type of inhibition), we have created the FF2-6-001 
qPCR set-up tool which is used to analyze preliminary 
qPCR Test Plate data generated by up to seven qPCR 
targets from serial progressive dilutions of representative 
(Stock I) RNA or cDNA mixtures all used in fluorogenic 
hydrolysis probe-based qPCR. Once Test Plate threshold 
cycle (CT) values are obtained for each target on any 
given Test Plate, they are entered into the 
TestPlateResultsAnalysis2006.xls portions of the FF2-6-
001 qPCR set-up tool which the user interacts with in 
order to quickly and precisely identify the useful RNA 
dilution ranges for each qPCR target – within these 
ranges which each target can be expected to amplify 
without inhibition, with LOG-linearity and with high 
efficiency. The FF2-6-001 qPCR set-up tool then applies 
these ranges to final qPCR reaction designs allowing the 
investigator to formulate high-fidelity qPCR reactions 
every time since the FF2-6-001 file system ensures that 
each real-time qPCR reaction is carried out under the 
most dynamically sound conditions possible for each 
different genomic or transcriptomic target of interest. As 
a result, investigators are able to consistently attain 
credible real-time qPCR target and housekeeper CT 
values. The FF2-6-001 qPCR set-up tool is also 
universally adaptable to any master mix and qPCR 
reagent-use selection (e.g. SYBR Green, one-step and 
two-step, beacon, scorpion and hydrolysis probe 
methods) for both relative and absolute quantitative 
qPCR approaches. Since real-time qPCR is lauded by 
many as the most powerful tool in all of molecular 
   
 
 
Gallup and Ackermann - Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system ‘FocusField2-6GallupqPCRSet-upTool-
001’ to attain consistently high fidelity qPCR reactions 
www.biologicalprocedures.com 
88
biology for quantitative analysis of gene expression, and 
since it is still considered the tool of choice for validating 
micro-array data, any new ideas, methods or approaches 
that improve its precision in common practice represent 
important constructive advances furthering the 
responsible evolution of an already broadly-accepted 
scientific technique.  
 
INTRODUCTION 
 
A variety of problematic inhibitory phenomena have 
been reported that plague qPCR assays (1). Inhibition of 
the enzymatic reactions involved in generating real-time 
qPCR signals from specific cDNA templates using 
specific primers, fluorogenic probes, or combinations of 
primers and fluorogenic probes can severely impact the 
precision of absolute and relative gene expression 
quantitative analysis. Any factor, experimental, user-
introduced, environmental or otherwise, that has an 
impact on the activity of RT (reverse transcriptase) 
enzyme and/or Taq polymerase used in any one-step 
real-time qPCR reaction will invariably affect the results 
generated. In worst-case scenarios, these deficiencies go 
unnoticed and remain unaddressed. Recently, others 
have suggested that many as-yet unidentified sample-
specific substances (or impurities) are often carried over 
as a result of different RNA isolation methods (preceding 
real-time qPCR of any variety) which cause RT enzyme 
or Taq DNA polymerase-based qPCR inhibition (1, 2). 
Exogenous contaminants such as glove powder and 
phenolic compounds from the extraction process and 
plastic-ware (pipette tips, tubes and plates) can also have 
an inhibiting effect. With regard to tissue-specific 
inhibition of DNA amplification, tissue type was found to 
be the largest source of variance of inhibitory 
phenomena while primer sequences appeared to have 
the least affect. In other words, tissue type from which 
total RNA was extracted had the most significant effect 
on PCR kinetics, thus on final threshold cycle (CT) values 
(1, 4). This is thought to be caused by different kinds and 
amounts of cellular debris present in samples after RNA 
extraction (2, 3). Endogenous contaminants such as blood 
or fat are thought to play an important role in affecting 
both the PCR as well as the preceding reverse 
transcription reaction. Other inhibitory contaminants are 
thought to be hemoglobin, heme, porphyrin, heparin 
(from peritoneal mast cells), glycogen, polysaccharides 
and proteins, cell constituents, Ca2+, DNA or RNA 
concentration, and DNA (and possibly RNA) binding 
proteins (5-12). MicroRNA (miRNA) is not thought to be 
a contributing factor to qPCR inhibition since high 
thermocylcing temperatures (94-95°C) most likely 
prevent the formation of stable RNA-binding complexes 
which might otherwise associate with template RNA 
(Ambion technical support information). 
 
Types of qPCR inhibition 
 
Because of the severe impact inhibition can have on 
results, we feel it is important to address it and attempt 
to identify the possible form(s) that may be present or 
active throughout real-time pPCR procedures (37). 
Toward this end, based on experimental observations of 
the dynamics of numerous real-time qPCR reactions, we 
have organized qPCR inhibitory phenomena into five 
semi-distinct categories; Types 1 through 5 (Figs. 1-6). 
We describe them as: inhibition of reverse transcriptase 
(RT) enzyme(s) and/or Taq DNA polymerase(s) by 
excessive rRNA and possibly tRNA in concentrated RNA 
samples (sample concentration-related template 
inhibition; Type 1 inhibition); inhibition from method of 
RNA isolation due to the carryover of inhibitory 
biological components or molecules (RNA isolation 
method-related inhibition; Type 2 inhibition); inhibition 
arising from the type of tissue or cell that sample RNA 
has been isolated from (sample-specific inhibition; Type 
3 inhibition); inhibition arising as a result of the 
interaction of a specific qPCR target template with sub-
optimal concentrations, designs or any other 
thermodynamic factors concerning its specific probe 
and/or primer(s) (target-specific kinetic inhibition; Type 
4 inhibition); and inhibition caused by compounds such 
as EDTA, GIT, TRIS, glycogen (sometimes used as a 
carrier agent during RNA isolation; inhibition of RT 
enzyme has been observed when glycogen is present in 
excess of 4 mg/ml during reverse transcription), (13, 14), 
or other user-introduced reagents (chemical inhibition; 
Type 5 inhibition). Although the reality of Type 6 
inhibition (connoting all other as-yet unknown causes of 
qPCR inhibition) looms large, for the purposes of this 
paper, only proposed inhibition Types 1 through 5 are 
addressed.  
 
Type 1 inhibition of reverse transcriptase (and possibly 
Taq DNA Polymerase) due to rRNA and tRNA is yet 
poorly understood, but it has been acknowledged and 
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referred to in product literature as being of serious 
concern (15). Understandably, inhibition Types 2 and 3 
will invariably be a function of one another since method 
of RNA isolation and tissue or cell type from which RNA 
is isolated will always affect one another distinctly, while 
all types of qPCR inhibition are diminished (and 
eventually eliminated) by sheer dilution of the RNA 
samples. Indeed, diluting RNA out too far can obviously 
result in the generation of weak or absent qPCR signals 
from lower abundance mRNAs in any transcriptome. 
Inhibition types 4 and 5 are more generally understood 
as they have been familiar concerns in the conventional 
PCR world since its inception in 1983. Since the qPCR 
studies used as examples in this paper involve the sole 
use of the TaqMan® (hydrolysis) probe method (which 
includes the use of sequence-specific forward and 
reverse primers), we discuss here only observations 
gathered by this approach using total tissue or cellular 
RNA in single-plex fluorogenic one-step real-time qPCR 
(Fig. 7). All reactions were run in an Applied Biosystems 
Incorporated (ABI) GeneAmp® 5700 Sequence Detection 
System unless otherwise stated (in one case, a Stratagene 
Mx3005P real-time qPCR machine was employed – using 
ABI TaqMan® One-Step RT-PCR Master Mix Reagents 
Kit). Any experimental results shown in this paper are 
meant to illustrate the unique prowess of the FF2-6-001 
qPCR set-up tool and to aid in discussing the concepts of 
qPCR inhibition and optimal qPCR target dynamic range; 
they are not intended to represent a complete scientific 
study per se. 
 
Inhibition encountered in experimental assays 
 
By examining the results from numerous one-step real-
time qPCR studies using total RNA isolated from 
mammalian tissue or mammalian cell cultures either by 
Trizol® (14), or a column purification method (Rapid 
Total RNA Purification System, Cat. No. 11502-050, 
Marligen), we found that a direct relationship existed 
between the severity of qPCR inhibition and the method 
used to isolate sample total RNA. This was a clear 
example to us that qPCR inhibition Types 2 and 3 were 
interrelated. Most Trizol®-isolated total RNA, when used 
in one-step real-time qPCR, showed inhibition until a 
final post-DNase, in-well (See Appendix 1) RNA dilution 
of ~1:150. At 1:200 final (post-DNase, in-well) RNA 
dilutions and beyond, most targets (i.e. SBD-1, ovTTF-1, 
ovSP-A, ovSP-D, ovICAM-1, SMAP29, bRSV and 
ovRPS15; see Appendix 14) showed lack of inhibition 
and began to behave as classic real-time qPCR templates. 
The only exception to this was hRIBO18S RNA, which 
did not exhibit normal real-time qPCR template behavior 
until a dilution of ~1:4,000 and higher (Fig. 2). 
Significantly less qPCR inhibition was observed with 
RNA samples that were isolated using the Marligen 
column-based method (Clark-Sponseller equine studies, 
2005-2006 unpublished). Inhibition for all samples 
disappeared at final (post-DNase, in-well) RNA dilutions 
of 1:50 and higher for equine targets IL-10, IL-12p35, IL-
12p40 and GA3PDH (Figs. 3, 4 and Appendix 14). Equine 
RIBO18S RNA was not studied, so the effect of Marligen 
column isolation on this target is unknown. Final, in-well 
RNA concentrations were never greater than 0.5 ng/µl in 
any of these qPCR studies (~0.3 ng/µl seemed to work 
the best), so inhibition of RT enzyme and/or Taq DNA 
polymerase by excess RNA in the reaction wells (Type 1 
inhibition) was reasonably eliminated as a source of any 
of the inhibition phenomena witnessed (since by the time 
most samples reached this final in-well concentration, 
they had already incurred dilutions of 1:3,000 or greater 
– certainly outside the range where most forms of 
inhibition would be reasonably expected, with the 
possible exception of inhibition Type 4) (See Appendix 
2). 
 
We further make the assumption that our one-step qPCR 
reactions are safely outside the realm where Type 1 
inhibition might be expected. This is based on product 
literature and guidelines from ABI and others that 10 
picograms to 100,000 picograms of total RNA per each 50 
µl one-step real-time qPCR reaction is generally 
considered to be the normal range within which one-step 
qPCR amplifications can be expected to exhibit favorable 
LOG-linear kinetics (2, 28, 29, 31, 39). Routinely, we 
design our final 25 µl qPCR reactions to contain no less 
than 0.005 pg of total RNA per 25 µl reaction (e.g. for the 
last point of typical standard curves for the hyper-
abundant housekeeper, 18S ribosomal RNA) and no 
more than 12,500 pg of total RNA per 25 µl reaction 
mixture (i.e. for often rarely-expressed targets such as 
SBD-1, IL-10, IL-8 and TNF-α). Above 12,500 pg total 
RNA per 25 µl reaction, we begin to observe problematic 
qPCR inhibitory phenomena (with Trizol®-isolated tissue 
total RNA) of Type 1, Type 2, Type 3 (and presumably 
Type 4) varieties. Interestingly, at first, the qPCR 
inhibition we observed seemed to be either a byproduct 
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of Turbo-DNase (Ambion) treatment (Type 5 inhibition), 
or rRNA and tRNA inhibition of the RT enzyme during 
reverse transcription (Type 1 inhibition). But, then it 
became apparent that this inhibition was more likely due 
to the method of total RNA isolation (our final Turbo-
DNase treated RNA samples never comprised more than 
26% of each final one-step real-time qPCR reaction 
volume; an amount that is safely within Ambion product 
literature guidelines regarding the proper use of Turbo 
DNase-treated RNA in qPCR reactions). In our studies, 
Trizol® RNA isolation (which we used for 15 different 
sheep tissues, 14 different chicken tissues, JS7 ovine lung 
cell and H441 human adenocarcinoma cell cultures) and 
Marligen column-based RNA isolation procedures (used 
for equine dendritic and macrophage cell cultures (Clark-
Sponseller, 2005-2006, Iowa State University)) were both 
followed by identical Turbo-DNase treatments. But, 
Trizol®-isolated RNA always showed a greater degree of 
qPCR inhibitory characteristics than Marligen column-
isolated RNA samples. Since all conditions were identical 
for these samples except method of RNA isolation, this 
indicated to us that qPCR inhibition Types 2 and Type 3 
were a function of one another. Further, in our studies, 
the possibility that Type 4 inhibition (target-specific 
kinetic inhibition) is a source of RT enzyme and/or qPCR 
(e.g. Taq DNA polymerase) inhibition seemed to be most 
probable only with the hyper-abundant 18S ribosomal 
RNA target, whereas inhibition of RT enzyme by rRNA 
(and possibly tRNA) and chemical inhibition seem to 
mainly affect those targets which are only able to elicit 
ample qPCR signals when using more concentrated RNA 
during qPCR. In our previous work, Type 5 inhibition 
was clearly demonstrated with LCM RNA samples that 
received EDTA during DNase-treatment preceding 
fluorogenic one-step real-time qPCR; the ABI one-step 
master mix used was especially prone to even very small 
exogenously-introduced amounts of EDTA (which of 
course forms a chelate with divalent metal ions such as 
Mg2+ – keeping them from participating as crucial co-
factors in enzymatic reactions such as reverse 
transcription and PCR) (16). 
 
All 5 proposed types of inhibition present themselves 
during two-step qPCR as well (using cDNA synthesized 
separately, prior to subsequent qPCR procedures), but to 
a much smaller degree than is seen during one-step 
qPCR for the identical target. The differences here can be 
largely ascribed to the amount of template present and 
available for qPCR since cDNAs synthesized prior to 
qPCR are often 20 ng/µl or less and have already 
incurred enough dilution in most cases (since template 
RNA isolation) to have minimized or eliminated the 
chances that any of the five currently-proposed causes of 
qPCR inhibition would be present. Corresponding RNA 
samples in the same regard are often 200-1,000 ng/µl 
before use. Quite logically, the more concentrated one 
must use RNA samples during one-step qPCR in effort to 
find “quieter” target signals of interest, the higher the 
risk there is of allowing qPCR inhibitory phenomena of 
any variety to manifest itself. Since our studies have 
expanded to the use of total RNA isolated from ovine 
lung, nasal turbinate, trachea, rumen, abomasum, 
jejunum, ileum, spiral colon, rectum, liver, gall bladder, 
urinary bladder, kidney, uterus (adult) and placenta 
(fetus) tissue, and chicken bone marrow, jejunum, crop, 
testes, oviduct, lung, skin, spleen, liver, kidney, bursa, 
trachea, conjunctiva, tongue, ovine and human lung cell 
cultures, and equine macrophage and dendritic cell 
cultures (courtesy of Dr. Brett Sponseller and Sandra K. 
Clark), we have witnessed and have successfully dealt 
with numerous different qPCR inhibitory profiles (using 
the FF2-6-001 qPCR set-up tool). Others have 
acknowledged the importance of this battle as well (1, 3-
12, 39). With regard to Trizol® versus Marligen column-
based RNA isolation, it is clear that inhibitory artifacts of 
RNA isolation can be augmented or diminished 
according to the method of RNA isolation employed, and 
by the extent of dilution RNA samples undergo prior to 
their use in qPCR. 
 
On account of the inability of investigators to find an 
RNA isolation method which will not introduce one-step 
real-time qPCR inhibition at some point, of some kind to 
some degree, we found it an absolute necessity to create 
a tool (FF2-6-001) that could quickly reveal the dilution 
ranges within which each real-time qPCR target of 
interest amplified without inhibition. Our approach 
emphasizes (as do methodologies offered of most 
companies that provide the world with qPCR 
technology) the importance of performing preliminary 
qPCR RNA template dilution studies for all targets every 
time RNA samples are isolated for the purpose of gene 
expression analysis. What ABI describes as a 
“validation” plate, we call a “Test Plate” (Figs. 18, 22 and 
28).  
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EXPERIMENTAL PROCEDURES 
 
Fluorogenic real-time qPCR; one-step versus two-step 
 
Fluorogenic one-step (for final relative quantitative 
target analyses) and two-step real-time qPCR (for initial 
target primer-probe optimizations; primers and probes 
designed using ABI Prism Primer Express™ version 2.0) 
were carried out as described previously (16-24). The 
fluorogenic 5ʹ nuclease assay (TaqMan® hydrolysis probe 
method) is a convenient, self-contained process which 
uses a fluorogenic probe consisting of an oligonucleotide 
to which a reporter dye and a quencher dye are attached. 
During PCR, the probe anneals to the target of interest 
between the forward and reverse primer sites. During 
extension, the probe is cleaved by the 5ʹ nuclease activity 
of the DNA polymerase. This separates the reporter dye 
from the quencher dye, generating an increase in the 
reporter dye’s fluorescence intensity. Once separated 
from the quencher, the reporter dye emits its 
characteristic fluorescence (Figs. 7 and 8). The threshold 
cycle, or CT value, is the cycle at which a significant 
increase in normalized reporter fluorescence, ΔRn, is first 
detected (See Appendix 3); where ΔRn is calculated from 
Rn+ and Rn-, where Rn+ is the Rn value of a reaction 
containing all components, and Rn- is the Rn value of an 
un-reacted sample (the baseline value or the value 
detected in the no-template control, NTC). ΔRn is thus 
the difference between Rn+ and Rn- and it is an indicator 
of the magnitude of the signal generated only by the 
fluorogenic PCR (25). For fluorogenic hydrolysis probe 
designs, we use ‘C-probes’ instead of ‘G-probes’ 
whenever possible since empirical data from ABI has 
shown that use of TAMRA-quenched probes containing 
more Cs than Gs improves the overall magnitude of 
fluorescent signal generated (i.e. greater overall ΔRn is 
observed). Primer-probe sets were also designed to span 
genomic introns whenever feasible; especially probe 
sequences. However, when deciding whether to use the 
sense or anti-sense probe sequence in each case, we were 
careful to avoid using C-probes which contained a G on 
the 5’ end (immediately adjacent to the reporter dye) – a 
feature that should be strictly avoided since Guanine is a 
potent inhibitor of reporter dye fluorescence. It is 
important to note here, however, that the “C-probe 
versus G-probe” rationale does not apply to minor 
groove-binding non-fluorescent quencher (MBGNFQ)-
based probes. The ABI GeneAmp® 5700 Sequence 
Detection System measures the increase in the reporter 
dye’s fluorescence during the thermal cycling of the PCR, 
and this data is then used by the sequence detection 
software to generate CT values for each target which we 
finish processing and interpreting using custom Excel 
files. We feel strongly that being able to process one’s 
own CT values into final quantitative results is 
paramount since qPCR machines of all varieties cannot 
discern between erroneous (either user- or machine-
introduced) signals and legitimate signals 100% of the 
time. Additionally, processing one’s own data (rather 
than allowing qPCR machine processing) not only 
acquaints one directly with the interesting mathematical 
terrain associated with qPCR, it also exposes one first-
hand to some of the fascinating intricacies and nuances 
associated with qPCR that are often not readily apparent 
to the user – all things which allow one to garner 
additional stratagems to apply to future troubleshooting 
and qPCR assay optimization endeavors. 
 
One-step real-time qPCR 
 
Fluorogenic one-step real-time qPCR differs from 
fluorogenic two-step real-time qPCR in three major 
regards: 1.) in a one-step approach, RNA is added 
directly as the nucleic acid template in qPCR reactions 
instead of cDNA, 2.) reverse primer concentrations have 
to be increased for use in one-step analyses due to first-
strand synthesis requirements and, 3.) a different master 
mix is employed for one-step as opposed to two-step 
qPCR. One-step reactions typically contain both reverse 
transcriptase and Taq DNA polymerase enzymes and are 
subjected to thermocycler programs which address both 
enzymes in turn. For one-step real-time qPCR, we use 
ABI Cat. No. 4309169, TaqMan® One-Step RT-PCR 
Master Mix Reagents Kit. In this kit, 250 µl of 
Multiscribe (MuLV) RT enzyme (10 U/µl) arrives 
already pre-mixed with RNase inhibitor (40 U/µl) as a 
40X solution. The one-step RT-PCR master mix in the kit 
(containing AmpliTaq Gold® hot-start DNA Polymerase, 
undisclosed amounts of MgCl2, A, C and G dNTPs and 
dUTP, 300 nM ROX passive internal reference molecule, 
other ABI-proprietary buffer components, but no 
AmpErase® UNG enzyme) arrives as a separate 2X 
solution (5 ml total). Each of our final 25 µl one-step real-
time qPCR reactions contains: 12.5 µl one-step master 
mix, 0.25 U/µl Multiscribe RT enzyme, 0.4 U/µl RNase 
inhibitor, optimal forward primer and fluorogenic probe 
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concentrations (as previously established for each target 
by two-step real-time qPCR according to classic ABI 
protocol, (25)), reverse primer concentrations adjusted 
for one-step use (See Appendix 4), nuclease-free water, 
and 6.5 µl of each RNA sample/template. Before use, all 
solutions are gently vortexed and spun down, then 
allowed to undergo fluorogenic one-step qPCR reactions 
using the following thermocycler conditions: 35 minutes 
at 48°C (for reverse transcription; normally 30 minutes; 
ABI), 10 minutes at 95°C (for AmpliTaq Gold® DNA 
polymerase hot-start activation), and 50 cycles of: 15 
seconds at 95°C (for duplex melting), 1 minute at 58°C 
(for annealing and extension; normally 60°C; ABI). For 
pipetting accuracy purposes, we always prepare enough 
of each reaction mixture to accommodate 30 µl reaction 
sizes but, in the end, use only 25 µl of each in the final 
reaction wells in 96-well qPCR reaction plates.   
 
Two-step real-time qPCR 
 
Our use of fluorogenic two-step real-time qPCR is now 
limited only to performing preliminary optimization and 
validation plates for brand-new target primers and 
probes since it is generally less expensive than the 
corresponding one-step procedure. Toward this end, for 
two-step qPCR, we use ABI Cat. No. 4304437 TaqMan® 
Universal PCR Master Mix 2X which contains AmpliTaq 
Gold® (hot-start) DNA Polymerase, undisclosed amounts 
of MgCl2, A, C and G dNTPs and dUTP (in order for the 
AmpErase® UNG system to work), AmpErase® UNG 
Enzyme, 300 nM ROX passive internal reference 
molecule, a PCR product carryover correction 
component and other proprietary buffer components. 
Primer optimization plates are run in a GeneAmp® 5700 
real-time PCR machine (GeneAmp® 5700 Sequence 
Detection System, ABI) using the following thermocycler 
conditions (a specific thermocylcer program created and 
optimized by ABI to be used specifically with the 
TaqMan® Universal PCR Master Mix 2X, and two or 
three other related ABI 2X Master Mix reagents):  Hold 
for 2 minutes @ 50°C to activate the AmpErase® UNG 
enzyme (See Appendix 5), Hold for 10 minutes @ 95°C 
(to “hot-start” activate the AmpliTaq Gold DNA 
polymerase) and then 50 cycles of 15 seconds @ 95°C (for 
duplex melting) followed by 1 minute @ 60°C (to 
accomplish the annealing and extension phases of the 
PCR). Each 50-cycle run lasts 2 hours and 14 minutes, 
after which the GeneAmp® 5700 sequence detection 
system software and custom Microsoft Excel files are 
used in conjunction with one another to analyze and 
interpret the resultant fluorogenic qPCR Rn or CT values. 
For all optimization trials, each sample is analyzed in 
either triplicate or quadruplicate. On the primer-
optimization plate for each target, primer amounts that, 
upon analysis, provide the highest Rn value with the 
lowest primer concentration(s) are identified as the 
optimal concentrations for each primer pair for each of 
the respective qPCR targets of interest. To test each probe 
for optimal efficacy, a second plate is designed for each 
target to enable the testing of various concentrations of 
each probe ranging from 25 nM to 225 nM in the 
presence of optimal primer concentrations (as already 
established by the primer-optimization plate in each 
case). For each probe, in each well, each 25 µl PCR 
reaction contains the [two-step]-identified optimal 
concentrations of each primer for each target, 2.5 µl of 1:5 
or 1:10-diluted Stock I cDNA (See Appendix 6), 12.5 µl 
of the ABI commercial master mix (mentioned above) 
and nuclease-free water. For the purpose of providing 
real-life examples for this paper, we address several 
targets of interest to us including: sheep beta-defensin-1 
(SBD-1), ovine thyroid transcription factor-1 (ovTTF-1), 
ovine surfactant protein A (ovSP-A), ovine surfactant 
protein D (ovSP-D), and housekeepers ovine ribosomal 
protein S15 (ovRPS15) and human 18S ribosomal RNA 
(hRIBO18S) (Figs. 22, 23, 27, 28 and Appendix 14). For 
these targets, we found optimal primer [two-step] 
concentrations in each case to be 300 nM and 900 nM for 
SBD-1, 1 µM and 1 µM for ovTTF-1, 300 nM and 300 nM 
for ovSP-A, 300 nM and 300 nM for ovSP-D, 1 µM and 1 
µM for ovRPS15, and 50 nM and 50 nM for hRIBO18S 
forward and reverse primer concentrations, respectively. 
For one-step analyses, (for reasons already discussed 
above regarding the partial use of reverse primers due to 
first-strand syntheses), these same primer sets were used 
at 500 nM and 1 µM for SBD-1, 1 µM and 1 µM for 
ovTTF-1, 500 nM and 500 nM for ovSP-A, 500 nM and 
500 nM for ovSP-D, 1 µM and 1 µM for ovRPS15, and 50 
nM and 50 nM for hRIBO18S RNA forward and reverse 
primer concentrations, again respectively. Each reaction 
mixture on each optimization plate for each target was 
run in triplicate or quadruplicate in order to bolster the 
statistical significance of sample assessments. In all cases, 
replicate sample well CT values never deviated more 
than 0.5% from one another, lending high credence to the 
technique’s consistency, stability and reproducibility 
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(Figs. 9 and 10). Probe-optimization plates were also run 
in the GeneAmp® 5700 sequence detection system using 
the same thermocycler program as used for the primer-
optimization plates. For analysis of the data from probe-
optimization plates, the combination of reactants that 
yielded the lowest CT values with the lowest probe 
concentrations were chosen as the optimal fluorogenic 
probe concentration in each case (which we found to be 
150 nM, 150 nM, 50 nM, 100 nM, 150 nM and 200 nM for 
SBD-1, ovTTF-1, ovSP-A, ovSP-D, ovRPS15 and 
hRIBO18S RNA probes, respectively – and we used these 
same probe concentrations for one-step qPCR as well). 
Next, as a validation test that target and endogenous 
reference (housekeeper) cDNA amplification reactions 
were all proceeding at acceptable efficiencies across a 
spectrum of Stock I cDNA concentrations, a third plate 
(the validation Test Plate) was designed to enable the 
testing of various concentrations of cDNA ranging from 
full-strength Stock I cDNA to a 1:15,625 (e.g. the seventh 
in a series of progressive 1:5 dilutions) dilution of Stock I 
cDNA. In each well, constant (optimal) concentrations of 
forward and reverse primers and constant (optimal) 
concentrations of probe were used along with 12.5 µl of 
ABI (Cat No. 4304437) master mix, 2.5 µl of sequentially-
diluted Stock I cDNA and nuclease-free water. Also 
included on this plate, were wells identical to the ones 
just described, but instead of ovine target primers and 
probe, they contained either the endogenous 
reference/housekeeper (hRIBO18S RNA) forward and 
reverse primers and probe at their optimal real-time 
concentrations (50 nM primers and 200 nM probe; as 
established by ABI for this target) or ovRPS15 forward 
and reverse primers and probe at their optimal 
concentrations. Validation plates included all samples in 
triplicate and were run in the GeneAmp® 5700 sequence 
detection system using the same universal thermocycler 
protocol as used for the primer-probe optimization 
plates, and resulting CT values were subsequently 
analyzed using custom Excel files (16, 19).  
 
RNA isolation and cDNA synthesis 
 
RNA isolation from whole tissue samples 
 
Briefly, entire tissue samples (1-2 grams of each in 
cryovials stored at -80°C immediately post-necropsy) are 
carefully weighed, placed immediately into 3 ml of 
Trizol® reagent inside nuclease-free 50 ml conical 
centrifuge tubes (Greiner-USA Scientific) and 
homogenized for 30 seconds using a TH OMNI 
Homogenizer (OMNI International, Inc.) to obtain 
Trizol®-tissue pre-homogenates. Measured amounts of 
Trizol® are then added to calculated portions of each pre-
homogenate to obtain 0.091 mg tissue per ml. This makes 
each tissue homogenate as experimentally similar as 
possible and ensures that the RNA extraction capabilities 
of Trizol® itself are not exceeded (as per manufacturer’s 
guidelines). After brief vortexing, 1.1 ml of each final 
Trizol®-adjusted homogenate is transferred to a nuclease-
free 1.5 ml vial (USA-Scientific) and allowed to sit for 5 
minutes at room temperature. 200 µl nuclease-free 
chloroform (Fisher Scientific) is added to each and tubes 
are shaken vigorously for 15 seconds. Samples are 
allowed to sit for 3 minutes at room temperature then 
microfuged at 12,000 x g for 10 minutes at 4°C. Top 
aqueous layers are carefully removed and transferred 
into new nuclease-free 1.5 ml vials, and 500 µl nuclease-
free 2-propanol (Fisher Scientific) is added to each. 
Samples are briefly vortexed, allowed to stand at room 
temperature for 10 minutes, then microfuged at 12,000 x 
g for 10 minutes at 4°C. Large white pellets are visible at 
the bottom of each sample tube at this point and the 2-
propanol is subsequently dumped from each tube 
followed by three washes with pre-cooled (-20°C) 75% 
nuclease-free ethanol prepared with nuclease-free water 
(Sigma-Aldrich, Ambion). The first two of these washes 
are carefully dumped off, while the third wash is 
vortexed until each pellet is swirling in solution to more 
fully wash any lingering guanidine isothiocyante (GIT) 
or other salts out from underneath each pellet – salts 
which might otherwise inhibit subsequent procedures. 
Next, all samples are microfuged at 15,300 x g for 5 
minutes at 4°C, the final 75% ethanol supernatant is 
carefully dumped off, and samples are air-dried for 
approximately 35 minutes under a fume hood. 170 µl of 
nuclease-free 0.1 mM EDTA (Sigma) prepared in HPLC-
grade water (Fisher) and adjusted to pH 6.75 is added to 
each pellet (See Appendix 7), each sample is vortexed 
briefly, heated to 65°C for 5 minutes (to aid in RNA 
pellet resolubilization), vortexed briefly again, then 
stored at 4°C. RNA isolates are then assessed at 1:50 
dilution for quantity and purity by spectrophotometry at 
260nm and 280nm followed immediately by DNase 
treatment with TURBO DNase (TURBO DNA-free kit, 
Ambion). Each DNase treatment reaction consists of 60 
to 70 µl RNA isolate, 8 to 18 µl nuclease-free water, 10 µl 
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10X TURBO DNase Buffer and 12 µl TURBO DNase 
enzyme. Reaction mixtures (100 µl each) are placed into 
an Applied Biosystems Incorporated GeneAmp® 2400 
thermocycler (Perkin Elmer/ABI) for 30 minutes at 37°C. 
1 µl DNase Inactivation Reagent per 10 µl solution is 
added to each tube. The tubes are incubated for 2 
minutes at room temperature with intermittent vortexing 
every 10 to 15 seconds, and then centrifuged at 10,000 x g 
for 3 minutes to pellet the Inactivation Reagent. Next, if 
RNA is to be used directly in one-step qPCR 
applications, 80 µl is carefully recovered from each 
DNase-treatment reaction; the upper transparent layer 
containing the RNA is transferred to a new tube (care is 
taken to avoid ~15-25% of the solution on the bottom of 
each tube – which is the pelleted Ambion DNase 
Inactivation Reagent polymer complex that can inhibit 
PCR reactions) and diluted 1:10 with nuclease-free water 
(Ambion) resulting in 800 µl of each RNA isolate to use 
for [FF2-6-001-calibrated] real-time qPCR analyses. 
However, for one-step qPCR analyses, it is important to 
note two things at this point: 1.) even at 1:10 dilution post 
DNase treatment, the RNA samples are still too 
concentrated to generate uninhibited qPCR target 
signals, and 2.) we never freeze the RNA samples from 
this point on before their use in qPCR; they are stored at 
4°C in nuclease-free 1.5 ml vials. Age-matched samples 
and Stock I solution-derived standards are run on the 
final qPCR plates. Prior to isolating total RNA from 
cultured cells, we collect cells from culture flasks by 
standard methods, pre-homogenize them in 1 or 2 ml of 
Trizol® by hand-pipetting, then store the resulting cell 
pellet-Trizol® pre-homogenates at -80°C until they are 
needed for total RNA isolation. 
 
To freeze or not to freeze RNA samples 
 
A controversial maneuver we perform is to never freeze 
our RNA isolates before use. One can freeze RNA 
isolates and use them later – but, we prefer to use them 
immediately to avoid any potential issues that might 
arise from freeze-thawing RNA. In order to minimize the 
potential effects of RNA degradation on qPCR results, 
we use only ‘age-matched’ RNA samples (RNAs 
isolated, DNase-treated and stored at 4°C on the same 
day) and corresponding standards (prepared from age-
matched Stock I solutions) during final one-step qPCR 
analyses. In the event that Stock I solutions are out of 
date with newer sample unknowns, previously-
generated age-matched standard curves are used for 
quantitative analysis. A major reason we currently avoid 
freezing RNA is based on our observations of shifts in 
target CT values after using freeze-thawed total RNA 
Trizol®-isolated from whole sheep lung in qPCR 
applications. These shifts, curiously, are often to lower CT 
values – indicating either improved reverse transcription 
efficiency (presumably due to less, or different secondary 
structures on shorter transcripts) (See Appendix 8) or 
possibly due to less reactants being used up during first-
strand synthesis (during reverse transcription) on 
account of there being shorter freeze-fractured/truncated 
transcripts to work with; leaving more reactants 
available during the fluorogenic PCR phase, thereby 
improving the ‘voracity’ of the PCR. But, no matter the 
reason, this was troubling enough that we have since 
avoided freezing tissue and cell culture RNA isolates 
entirely. However, we have indeed observed that rarer 
targets (i.e. IL-10) in Stock I solutions tend to exhibit 
steadily weaker qPCR signals over a three month period, 
but it is not clear yet if this indicates degradation of RNA 
stored at 4°C, or if it is the result of using primers and 
probes that have been repetitively freeze-thawed. One of 
the features of a closed system is that it eventually breaks 
down; so we advise investigators to use their RNA 
samples and Stock I preparations as quickly as possible 
(when using real-time one-step qPCR). Two-step real-
time qPCR has the added advantage that cDNA is more 
stable, but, even with one-step real-time qPCR; 
transcriptomic profiles are skewed to some degree 
always in direct accordance with the method of reverse 
transcription used.  
 
Laser capture microdissection (LCM)-derived RNA 
sample isolates 
 
We have developed a different line of reasoning 
altogether to handle RNA obtained by laser capture 
microdissection (LCM). Because there is precious little 
RNA in most LCM-acquired RNA isolates, we have not 
studied the behavior of LCM RNA samples under as 
many different conditions as we would like to. In 
addition, the fact that LCM-derived RNA samples are 
often tiny to begin with (e.g. 25 cells worth of RNA-
containing total cell isolate) also means that it cannot 
withstand some of the immense dilutions spoken of 
elsewhere in this paper. But, we have used unfrozen and 
once-frozen LCM-derived total cell extracts directly in 
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real-time one-step qPCR without noticeable differences 
in final results as long as samples were isolated from 
sections less than 8 days old in each case (16). In 
addition, given the different methodologies involved, 
there is no reason to think that the same rules would 
apply to LCM-derived RNA as apply to the relatively 
abundant RNA we get from tissues and cell cultures; 
extraction methods are different, carryover of potentially 
inhibitory biological material during RNA isolation is 
minimal, and sample component composition during 
qPCR is different (See Appendix 9). Truly, one of the 
great features of real-time qPCR is that it relies on very 
small sequence regions for successful amplification (~150 
bases or less typically). The law of averages would seem 
to favor the notion that the very small real-time qPCR 
regions of amplification will be left intact after multiple 
sample freeze-thaws and even outright RNA 
degradation – which is the very reason that real-time 
qPCR still yields spectacular results on highly-abused 
nucleic acid samples. In fact, we have demonstrated that 
extensively-freeze-thawed, five-year-old whole lung 
tissue Trizol®-isolated total RNA used in one-step real-
time fluorogenic qPCR generated nearly identical CT 
values for several targets as it did on the first day of its 
isolation (RNA sample from ewe 265, Caverly-Grubor-
Gallup-Ackermann, 2002 unpublished). Because of this, 
we believe real-time qPCR will remain one of the most 
important, reliable tools for genetically analyzing very 
old and degraded RNA and DNA samples given its 
extreme sensitivity and modest requirement that only 
very small stretches of nucleic acid sequences within 
samples need remain intact. 
 
cDNA synthesis using SuperScript™ III and a custom 
reverse transcription buffer 
 
When two-step qPCR is to be run, instead of diluting 
RNA isolates 1:10 post-DNase treatment, they are each 
diluted to 59.4 ng/µl and used as templates for 
complementary deoxyribonucleic acid (cDNA) synthesis 
(for use as samples or Stock I cDNAs in two-step qPCR); 
we use SuperScript™ III RT enzyme (Invitrogen) for 
reverse transcription. We prepare and use our own 10X 
reverse transcription buffer formulation (300 mM 
TRIS:HCl, 625 mM KCl, pH 8.3) in order that the ionic 
strength of our resulting cDNA solutions is similar to the 
ionic strength of the two-step master mix we use 
(TaqMan® Universal PCR Master Mix 2X, ABI). Briefly, 
reverse transcription master mix containing 3.38% 
nuclease-free water, 31.17 mM TRIS, 64.94 mM KCl, 5.71 
mM MgCl2, 2.08 mM dNTP mix, 2.6 µM random 
hexamers and 0.0222 µg/µl TURBO DNase-treated RNA 
is heated for 5 minutes at 65°C then snap-cooled on ice 
for at least 1 minute. We pre-dilute our TURBO DNase-
treated RNA samples (to 59.4 ng/µl) so that adding 36 µl 
of each RNA to each final 100 µl reverse transcription 
reaction results in all reactions containing 2.1389 µg total 
RNA. Two to four such 100 µl reactions are created from 
the same original reverse transcription master mix for all 
samples. Samples are spun down, and RNAse inhibitor 
(20 U/µl, ABI) and SuperScript™ III RT enzyme (200 U/µl, 
Invitrogen) are finally added to each cooled sample 
reverse transcription mixture (now 200 to 400 µl each). 
The final concentrations attained of each reverse 
transcription component are: 3.25% nuclease-free water, 
30 mM TRIS, 62.5 mM KCl, 5.5 mM MgCl2, 2 mM dNTPs 
(0.5 mM each of dATP, dCTP, dTTP and dGTP), 2.5 µM 
random hexamers, 3.5 U/µl SuperScript™ III RT enzyme, 
0.4 U/µl RNAse inhibitor and 0.021389 µg/µl TURBO 
DNase-treated RNA. These reagents are vortexed gently, 
split into 100 µl amounts into nuclease-free 0.2 ml tubes 
(Midwest Scientific), and the tubes are placed into the 
GeneAmp® 2400 thermocycler (which only accepts 
samples of 100 µl or less) for reverse transcription using 
thermocycler conditions of: 5 minutes at 25°C, 45 
minutes at 53°C, 15 minutes at 70°C, followed by a safety 
hold at 4°C. 
 
Concerns over the use of cDNA in two-step fluorogenic 
real-time qPCR 
 
For those who prefer to make their own cDNAs 
beforehand in pursuit of two-step real-time qPCR as the 
relative quantitative tool of choice, it is interesting to 
note that cDNAs, when reverse transcribed from Trizol®-
isolated RNAs showing original sample o.d.260nm readings 
(at 1:50 dilution) of 0.011 to 0.022 and higher are (by the 
time they are synthesized and diluted i.e. 1:10 before use 
in qPCR) already safely outside the dilution range where 
most qPCR inhibition would exist. For column-isolated 
RNAs, the lowest acceptable original o.d.260nm value at 
1:50 dilution for each RNA isolate can be calculated to be 
about 0.00275 to 0.0055 in the same regard. These 
observations apply to fairly standard reverse 
transcription reactions wherein 2 µg of RNA is used per 
each 100 µl reverse transcription reaction for cDNA 
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synthesis (according to standard ABI practice) whereas 1 
µg of RNA is used per each 100 µl reverse transcription 
reaction during Invitrogen SuperScript™ II reverse 
transcription reactions. Additionally, to improve the 
overall yield of cDNA synthesis reactions, it has been 
recently noted that priming reverse transcription 
reactions with random pentadecamers (as opposed to 
random hexamers or other primers) boosts cDNA yields 
by 2-fold while increasing the number of detectable 
transcripts by 11-fold (26) (See Appendix 10). In our 
experience, qPCR inhibition is still evident with the most 
concentrated cDNA standards or samples examined for 
the presence of the frequently-used housekeeping gene, 
18S ribosomal RNA, so care should be taken to dilute all 
similarly destined cDNAs at least 500 to 1,000-fold 
further before trustworthy CT values can be generated 
from such robustly-abundant target transcripts (See 
Appendix 11). An additional caveat to note regarding 
two-step real-time qPCR is that rare targets are often not 
amplified as efficiently by two-step as they are by one-
step real-time qPCR. This, we have concluded, is the very 
result of cDNA templates already having suffered 
considerably more dilution along the way from RNA 
isolation, through reverse transcription reactions and any 
additional dilutions before qPCR takes place. We have 
found our strongest qPCR signals from rare targets using 
one-step as opposed to two-step real-time qPCR. Further, 
by setting up one-step real-time qPCR plates in strict 
accordance with what the FF2-6-001 qPCR set-up tool 
(see Figs. 11 through 39 for depictions and descriptions 
of the different portions of the FF2-6-001 file system) 
reveals to us about the proper dynamic range of each 
target, we avoid diluting our RNA samples too much or 
too little and are therefore able to preserve maximal 
qPCR signal strength from each target amplification of 
interest while at the same time avoiding all qPCR 
inhibitory phenomena. Real-time signal (either target or 
housekeeper-derived) contributions generated from 
genomic DNA-contaminated samples during qPCR can 
be mathematically addressed by custom files as well (Fig. 
42).  
 
Housekeeping gene considerations 
 
Another area of concern has been choosing appropriate 
housekeepers for qPCR, and most recently it appears that 
ubiquitin, various transcription and elongation factors, 
transferrin receptor and several ribosomal protein 
mRNAs are among the most stable housekeeping signals, 
whereas GA3PDH, β-actin, β-tubulin and even 18S 
ribosomal RNA have been given progressively more 
negative and mixed reviews in this regard. Since 18S 
rRNA is a more globular structural form of RNA (and 
therefore likely subject to different degradative stresses 
or processes than mRNA), it is being increasingly 
thought of as a poor representative of linear transcripts 
in general (comment by Jim Wicks, Ph.D., PrimerDesign 
Ltd). It is also possible that the same housekeeper’s 
usefulness may vary from tissue to tissue, but Ubiquitin 
still seems to be quite stable in this regard (1, 2). 
However, in vivo (endogenous) housekeepers may 
become a thing of the past as more investigators explore 
the use of in vitro synthetic constructs or transcripts from 
highly disparate species (which exhibit no homology 
with the genome of the species being studied) – e.g. a 
jellyfish photoprotein (aequorin; GenBank accession 
number L29571) cRNA was successfully used as a 
‘reference gene’ (as an externally-introduced 
‘housekeeping’ gene) in recent murine studies at the 
University of Bonn, in Bonn, Germany. The foreign 
reference jellyfish cRNA was found to be just as reliable 
as three other endogenous murine housekeeping genes 
(β-actin, GA3PDH and HPRT1) in that study (29). 
Normalization of gene expression using expressed Alu 
repeat elements is also currently being proposed (40), 
which will be highly useful for primate RNA samples. In 
addition, RNA samples taken from other mammalian 
genomes (for the purposes of qPCR) which house 
similarly unique (species-specific) repetitive genetic 
elements (many of which, like Alu sequences, are found 
within the untranslated regions of numerous mRNAs 
throughout the transcriptome), (41), might also take 
advantage of this approach, while RNA samples from 
animals with indigenously fewer unique repeats, such as 
birds, may benefit little from it (42). 
 
Review of basic real-time qPCR math 
 
Crucial to the proper interpretation of any real-time 
qPCR data is a clear understanding of the mathematical 
principles underlying generation of the data. Though it is 
not the intent of this manuscript to promulgate the entire 
possible range of the math involved, it is nonetheless 
important to touch on the most relevant equations and 
concepts; some of which are likely generally familiar and 
   
 
 
Gallup and Ackermann - Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system ‘FocusField2-6GallupqPCRSet-upTool-
001’ to attain consistently high fidelity qPCR reactions 
www.biologicalprocedures.com 
97
accepted, and one or two of which may be unique. In 
brief, the ideal slope (m) of the dilution curve for any 
real-time qPCR target is invariably -1/LOG10(2) or the 
value “-3.3219…” etc. Such a slope indicates a reaction 
Efficiency or ‘Efficacy’ (E) of 1 (or 100% Efficiency), 
which correlates to an Exponential Amplification (EAMP) 
value of 2 (indicating a perfect doubling of template 
every cycle). When efficacy of template doubling per 
cycle is sub-optimal, E <1 and EAMP <2, e.g. if E = 0.83, 
then EAMP = 1.83 since the expressions for E and EAMP are 
[10(-1/m) – 1] and 10(-1/m), respectively. When E is not 
known, the expression, “2∆∆Ct” (or “2-∆∆Ct”) can 
sometimes be used to compute the approximate fold 
change in gene expression between control and treated 
samples (or normal vs. abnormal, diseased vs. non-
diseased, or any sample vs. an appropriately-selected 
“calibrator” sample, etc.), but this expression is simplistic 
in that it entirely ignores the impact that E has on the 
target and housekeeper reactions in each case (36). When 
E is known for targets and housekeepers, the 2-∆∆Ct 
expression can be expanded into: Fold increase = (2 x 
E)∆∆Ct where the term “∆∆CT” = [(CTtarget,control-
CThousekeeper,control)-(CTtarget,treated-CThousekeeper,treated)] (27). This 
(“expanded 2∆∆Ct”) equation generates similar (though 
not identical) results to the “Pfaffl Equation” (28) and the 
“ISU Equation” (see below) only when the term “(2 x E)” 
is replaced by the more precise term “(1 + E)” to yield the 
corrected “expanded 2∆∆Ct” equation: Fold increase = (1 + 
E)∆∆Ct. Use of the term “(1 + E)” here is more appropriate 
since it is in direct keeping with the original universal 
expression for all PCR amplifications: “Xn = Xo(2)n,” 
which, for less-than-100%-efficient reactions, by necessity 
becomes: “Xn = Xo(1+E)n.” In this equation, “Xo” 
represents the initial number of target copies, “n” 
represents the number of cycles elapsed, “Xn” represents 
the number of target amplicons generated after “n” 
cycles, and “E” = Efficiency ([10(-1/m) – 1]), (36). When the 
term “(2 x E)” is used (27), the “expanded 2∆∆Ct equation” 
is prone to underestimating fold differences between 
samples, whereas using 2∆∆Ct, by itself, consistently 
overestimates fold differences since it is inherently 
erroneous in that it assumes all qPCR reactions to be 
100% efficient. 2∆∆Ct is nonetheless a very helpful and 
informative approximation when efficiencies are 
unknown.  
 
Efficiency of reaction versus exponential amplification 
 
It is always important for one to differentiate between 
“E” and “EAMP” since the Pfaffl Equation uses “EAMP” 
instead of “E” when solving for relative quantitative and 
absolute quantitative gene expression results. These two 
terms are often confused in the literature and are 
mistakenly represented as interchangeable, which they 
are not. As a result, investigators can be thrown off 
course during the computation of their qPCR results. The 
Pfaffl Equation can be written as follows: 
 
Ratio (or fold change) = (Etarget)∆Cttarget(control - treated) / 
(Ehousekeeper)∆Cthousekeeper(control - treated) 
 
where R = “ratio” or calculated fold change in a specific 
target gene’s presence or expression level when 
comparing RNA isolated from a treated (or infected) 
plant or animal tissue or cell type to RNA from the 
corresponding normal, control or calibrator RNA 
samples (28). The value often written as “E” in the Pfaffl 
Equation is indeed “EAMP”; 10(-1/m), and should not be 
confused with the symbol “E” which connotes 
amplification reaction efficiency; [10(-1/m) – 1]. In addition 
to the Pfaffl Equation, there is another important partial 
equation that can be repetitively incorporated into a 
mathematical expression to form an equation (the ISU 
Equation) which generates values identical to that of the 
Pfaffl Equation. However, the ISU Equation makes room 
for the investigator to plug in the values of “m” and “b” 
from target and housekeeper standard curves and is 
derived from a partial equation indirectly alluded to in 
ABI User Bulletin #2 (31), namely: “Qty = 10((Ct-b)/m),” 
where “Qty” = the relative calculated quantity for any 
target, CT = the observed CT generated for the particular 
target or housekeeper being evaluated, and “m” and “b” 
are the slope and y-intercept, respectively, of that target 
or housekeeper’s standard curve (which are plots of 
LOG10 of the Stock I or sample dilution factors or “LOG10 
input,” versus CT). The expression “Qty = 10((Ct-b)/m)” can 
be directly assembled into the ISU Equation in the 
following way:  
 
Ratio (or fold change) =  
 
[(Qtytreated,[target]) /(Qtytreated,[housekeeper])] divided by: 
[(Qtycontrol,[target]) /(Qtycontrol,[housekeeper])]  
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Notice that, implicit in the ISU Equation, are the 
Efficiency (E) values for housekeeper and target gene 
amplifications by virtue of the equation’s direct inclusion 
of “m” and “b” values from the corresponding target and 
housekeeper standard curves. Although one finds that 
the Pfaffl and ISU equations both generate identical 
results, be aware that these values are not yet amenable 
to sound statistical analysis – the resulting values must 
be logarithmically transformed, using any logarithmic 
base (Figs. 40 and 41). We have chosen to transform to 
LOG base 2 values (LOG2) in accordance with Gilsbach et 
al. (29). In this form, qPCR (and PCR) data of any kind 
appropriately lends itself to correct parametric, t-test 
and/or box-plot statistical analyses (29, 30, 43 and Dr. 
Marcia de Macedo, 2004 unpublished). We LOG 
transform our qPCR data as soon as we have calculated 
our relative quantity values (either before or after 
division by housekeeper values). Subsequently, 
treatment group averages, standard deviations within 
treatment groups and standard error of the mean (s.e.m.) 
error bar ranges are all calculated from the LOG-
transformed quantity values. Once this first stage of data 
processing is complete, control group averages are then 
directly subtracted from themselves and all related 
treatment group averages (so all control groups appear 
at “0” level expression), a maneuver which is supported 
by the law of logarithms wherein LOG A/B = (LOG A – 
LOG B), and finally, new standard error bars are 
recalculated using the equation: 
 
 
 
which can be derived through statistical variance 
equations. LOG transformation of PCR data of any kind 
is a necessity – it is the nature of PCR to show higher 
variability with lower mean quantity values due to the 
ever increasing Monte-Carlo effect with decreasing 
presence of target template in nucleic acid samples (2, 
37). This reality is exposed only after LOG transforming 
quantitative qPCR data. If PCR data is not LOG 
transformed, one tends to see an opposite, 
counterintuitive trend: i.e. increasing variance with 
higher relative quantity means – which is definitely not 
true as many qPCR investigators can certainly attest to 
(2, 29, 30, 43). The trend most commonly observed in 
qPCR shows that final quantitative results generated 
from consistently lower CT values are generally more 
stable from replicate to replicate, from sample to sample 
(low variance), but once target or housekeeper CT values 
rise above 40, quantitative data begins to exhibit greater 
and greater degrees of statistically unacceptable variance 
due to the Monte-Carlo effect in addition to the 
background “noise” of the assay itself (resulting from the 
increasing accumulation of, and fluorescent signals from 
cleaved or displaced probe fluorogens and/or 
fluorescence-capable quenchers as the PCR proceeds) 
(32, 33). In our work, it has often been informative to 
additionally categorize qPCR targets according to the CT 
range within which we usually expect them to appear 
during qPCR. Since CT values are directly indicative of 
original target template abundance, we have created four 
categories into which most qPCR targets seem to fit, 
namely: 1.) rare transcripts; (CT range of 38-47), 2.) 
intermediate-abundant transcripts; (CT 26-37), 3.) 
abundant transcripts (housekeepers such as GA3PDH, β-
actin, β-tubulin and RPS15); (CT 20-25), and 4.) hyper-
abundant transcripts (i.e. 18S ribosomal RNA); (CT 12-
19). It is within the latter portion of the “rare transcripts” 
CT range noted above that investigators can also expect 
to experience the Monte-Carlo and assay “noise” effects 
to some degree. This “rare transcript” status can result 
from target mRNA being either endogenously rare by 
nature, made rare by experimental treatment or disease, 
by sheer sample degradation, or by over-diluting 
template-containing RNA or cDNA samples during 
qPCR set ups.  
 
qPCR sample dilution and CT relationships 
 
To continue, the final important mathematical 
relationships which are essential to one’s understanding 
of the ‘mathematical terrain’ associated with qPCR 
include the following interesting expressions: 
 
A.) 2λ = f, where “λ” = the ideal expected frequency of 
appearance of CT values for any dilution series between 
or among samples and “f” = the known dilution factor 
between or among samples. Expression A can be 
rearranged to give expression B: 
 
B.) λLOG10(2) = LOG10(f), which can be rearranged 
further into expression C: 
 
C.) λ = LOG10(f)/LOG10(2), which can be rearranged to 
result in an interesting expression for Efficiency (not 
Exponential amplification) using the same variables: 
 
D.) E = f(1/λ) - 1, or: E = f(1/Δλ) - 1 (when “f” is known), and 
E = ∆f(1/λ) - 1 (when “λ” is known) 
s.e.m.2 x  +  s.e.m.2 y
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The utility of expressions A and C above become 
immediately obvious when one realizes, for instance, 
that a serial 1:2 progression of diluted standards should 
ideally generate curves crossing threshold (generating CT 
values) at a frequency of “LOG10(f)/LOG10(2)” or 1 cycle 
apart; since f = 2 in this case, the final expression here 
becomes “LOG10(2)/LOG10(2) = 1.” If the serial 
progression were 1:7, CT values obtained from the 
corresponding amplification curves would be expected 
to be spaced “LOG10(7)/LOG10(2)” or 2.80973 cycles apart. 
When serial progressive dilutions of samples are 1:10, CT 
values from the amplification curves would be expected 
to be spaced “LOG10(10)/LOG10(2)” or 3.3219 cycles apart, 
and so on. On the other hand, when solving for “λ,” if for 
instance the observed CT values of a progressive target 
dilution series were observed to be about 2.3219 cycles 
apart, one can calculate that the progressive dilution 
series factor is “2λ” or 22.3219 or “5” (indicating that the 
underlying dilution pattern was based on serial 
progressive 1:5 dilutions of the qPCR sample RNA, 
cDNA, Stock I, viral RNA or DNA, etc.). This 5-fold 
difference in initial target template amounts between 
samples reveals the utility of the expression, “2∆CT”, or 
“2λ”, in that 2λ(target) divided by 2λ(housekeeper) approximates 
the Pfaffl equation, and EAMPλ(target) divided by 
EAMPλ(housekeeper) is the Pfaffl equation. By additionally 
dividing the resulting value of the above expression, 
[2λ(target) / 2λ(housekeeper)], by the 2λ value of a calibrator 
sample, one achieves efficiency-uncorrected “2∆∆CT” (or 
“2-∆∆CT”) analysis of qPCR data (36). On the other hand, 
dividing the resulting value of the expression, [EAMPλ(target) 
/ EAMPλ(housekeeper)], by the EAMPλ value of a calibrator 
sample, one achieves efficiency-corrected “EAMP∆∆CT” (or 
“EAMP-∆∆CT”) analysis of qPCR data. Values generated by 
this latter equation are identical to results obtained from 
both Pfaffl and ISU equations. When fold change in gene 
expression is not calculated in comparison to a calibrator 
sample’s target expression levels, the equations [2λ(target) / 
2λ(housekeeper)] or [EAMPλ(target) / EAMPλ(housekeeper)] suffice to 
reveal fold differences in target gene expression between 
samples. But, in order to statistically assess the data 
generated by any of these equations correctly, LOG-
transformation of quantity values is required beforehand 
(29, 30, 36). Any departures from expected CT frequencies 
(λ) of course indicate departures from ideal amplification 
reaction efficiencies, and for dealing with non-ideal 
situations (which predominate in practice), we have 
developed the equation, -LOG10(f) x (1/LOG10(2) - 
((1/LOG10(((10(1/((∆Ct)/LOG10(f))))))))), to predict CT 
appearances for any dilution factor between or among 
samples at any amplification reaction efficiency (E). The 
FF2-6-001 qPCR set-up tool is based on such equations.  
 
Efficiency of target amplification concerns 
 
It is important to note that the efficiencies of qPCR 
amplification reactions are initially only as good as 
primer and/or probe designs allow. But, equally 
important are the nucleic acid template dilutions used on 
a per-target basis. Greater than 100% efficiency 
(indicative of Type 1 inhibition in our experience) may be 
observed, and different primer-probe designs (even for 
the same target) will exhibit varying degrees of 
susceptibility (or be differentially prone) to each type of 
inhibition. These potentially confounding phenomena 
indeed present ongoing challenges to enzymologists and 
other scientists to further elucidate the molecular 
mechanisms underlying each particular form of qPCR-
related inhibition. In general, the slope of a qPCR target 
standard curve is the best indicator of whether or not 
there are problems with one’s qPCR primer-probe 
designs or template dilutions. Further, after optimizing 
primers and probes and determining optimal template 
dilutions for each qPCR target, by running standard 
curves for all targets on each qPCR plate, one can 
logistically side-step two common qPCR pit-falls: 1.) 
since all qPCR reactions for each target on a plate can be 
assumed to be governed by the same target-specific 
reaction efficiency (or indeed, inefficiency), including 
standard curves on each plate (for each target) essentially 
controls for plate-specific variations for each qPCR target 
since all same-qPCR-target samples on any given qPCR 
plate will be judged on the same ‘kinetic playing-field’ as 
their standard curves (i.e. all sample targets and their 
corresponding standards on each plate can be thought to 
have experienced the same environment together 
throughout a qPCR amplification) and, 2.) ordering and 
testing multiple primer-probe sets for the same target is 
cost-prohibitive for many labs (unless one is willing to 
sacrifice time and target specificity by using SYBR Green-
based real-time assays during optimization). Preparing 
standard curves for each different target on each plate 
provides a reliable way for investigators to get valid 
qPCR information even when using sub-optimal primer-
probe designs as long as the Monte-Carlo effect is not 
present as an additional, confounding factor (2, 37). It is 
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important to emphasize that these ideas appear to be 
most rigorous in the aftermath of running a proper Test 
Plate for all targets beforehand. It has been our 
experience almost 100% of the time, that when we design 
our real-time primer-probe qPCR sets using Primer 
Express v. 2.0, our resulting observed reaction 
efficiencies are consistently in the 90-110% range – but, 
again, only after we have responsibly performed the 
appropriate Test Plate(s) and analyzed the data using 
the FF2-6-001 qPCR set-up tool.  
 
The high importance of running a Test Plate 
 
On occasion, one may observe larger departures from 
ideal efficiencies among series of plates using the same 
standard curve template source, but, even then, 
efficiencies as low as 60% and as high as 140% can still be 
used to acquire credible data if the standards and 
samples on a single plate are weighed against one 
another for that plate alone and not cross-compared to 
results from other plates which have exhibited 
significantly different efficiencies for the same targets. 
However, when identical standards and/or inter-plate 
calibrators generate nearly identical CT values for the 
same target(s) from plate to plate, investigators can 
directly compare results among plates with confidence. 
Still, far and above any other single issue regarding one-
step qPCR optimization, we are solidly convinced that 
the most powerful thing one can do to attain ideal (or 
near-ideal) efficiencies from any qPCR target 
amplification is run a Test Plate to physically determine 
which specific RNA dilution ranges work best for each 
different qPCR target. For a good example of this see 
Figures 5 and 6. The three (never-before-tried) primer 
and probe sets used in this particular study/example 
(Brockus-Harmon-Gallup-Ackermann, 2006 unpublished) 
were designed using Primer Express v.2.0, never (two-
step)-optimized, and used directly at ‘saturating 
concentrations’ in each case (i.e. primers at 1 µM, and 
probes at 150 nM). After running a Test Plate for all 
three targets to identify the optimal RNA dilution range 
for each, we were able to obtain virtually 100% efficiency 
from each target amplification in the final qPCR study. 
Since we have repeated this approach successfully 
numerous times with other genes, we are confident that 
it is template dilution that affects the efficiency of real-
time qPCR reactions to the greatest degree – barring any 
obvious thermodynamic flaws in real-time qPCR 
primer/probe designs or reaction formulations. Again, 
any qPCR RNA sample’s ability to inhibit qPCR 
reactions can be diminished and eventually eliminated 
entirely the further one dilutes RNA samples in effort to 
attain the useful ranges for each target (as dictated by 
what one discovers by appropriate Test Plate analyses). 
There is indeed a “happy sample dilution range” for 
each qPCR target. 
 
The effect(s) of sheer sample dilution 
 
In most cases, useful RNA dilution ranges are so dilute 
(with respect to the originally-isolated RNA samples 
themselves) that most qPCR inhibitory phenomena has 
already been eliminated by the time the reactions are 
run. Factors known and unknown (which would 
normally bring about real-time qPCR inhibition when 
more concentrated sample RNAs are used) present no 
threat to qPCR reaction kinetics whatsoever after ample 
RNA sample dilution has occurred. Once ideal qPCR 
template dilution ranges are established for each 
different target, intended real-time qPCR reactions are 
allowed to proceed undaunted by inhibition of any kind. 
In this way, one can use the sensitivity of the real-time 
qPCR technique itself in its own favor since most targets 
can be detected – even when RNA is diluted extensively 
(e.g. most housekeepers still give robust qPCR signals 
even when diluted out beyond 1:1,000,000!) (See 
Appendices 11 and 12). Template dilutions thus serve a 
two-fold purpose: 1.) they achieve optimal template 
concentrations for each qPCR target of interest, and, 2.) 
they aid in greatly reducing and eliminating all potential 
forms of qPCR inhibition. Real-time qPCR inhibition can 
indeed be muted and even eliminated merely by RNA 
sample dilution in most cases, therefore leaving all 
nucleic acid target templates within each RNA sample 
genuinely available to participate in highly efficient (and-
therefore-quantitatively-accurate) qPCR amplifications. 
Once rendered non-existent by dilution, it simply doesn’t 
matter what type of sample-related inhibition could have 
had the potential to manifest itself during qPCR using 
more concentrated RNA; once it is carefully and 
premeditatedly eliminated by dilution, it is no longer of 
any consequence. Clearly, preliminary qPCR Test Plates 
serve to verify where each target reaction’s optimal, non-
inhibitory RNA dilution range is by examining an RNA 
sample (or mixture of RNA samples, i.e. Stock I) that is 
truly representative of all RNA samples examined in 
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each particular qPCR study. In the event that the optimal 
dilution of an RNA sample for a rare-but-present qPCR 
target impinges on that target’s ability to amplify, further 
purification of sample RNA may be necessary to 
minimize its inhibitory characteristics (2). Toward 
addressing and attaining each of these important 
objectives, the FF2-6-001 qPCR set-up tool is well suited 
since it enables investigators to entirely avoid over- or 
under-diluting RNA and DNA samples. 
 
Finding optimal dilution ranges for each qPCR target by 
running a Test Plate 
 
Before a qPCR Test Plate procedure can be correctly 
performed, it is often helpful that all qPCR primers and 
probes have already been optimized on cDNA template 
(by two-step qPCR) weeks or months prior to using them 
in hydrolysis probe-based fluorogenic one-step qPCR 
reactions. Or, if optimization is not affordable cost or 
time-wise, one may simply use saturating concentrations 
of primers (1 µM) and probes (150 nM) for all targets. 
Additionally, if two-step optimizations have already 
been carried out, reverse primer concentrations should 
all be increased at least 200 nM in each case (for use in 
one-step qPCR) unless saturating concentrations are 
already being used. Reverse primers are more highly 
exhausted by one-step than two-step qPCR on account of 
their being incorporated into the amplicons during first-
strand synthesis (16). By running a preliminary, 
universally-useful qPCR template dilution Test Plate 
(Figs. 18 and 22) for all targets in a one-step real-time 
qPCR assay over a (post-DNase, in-well) dilution range 
spanning from 1:38.46 to 1:5,000,000) of a representative 
RNA sample or RNA mixture (See Appendix 13), we 
quickly identify the useful dilution ranges for each 
particular qPCR target by using FF2-6-001 custom Excel 
files TestPlateResultsAnalysis2006.xls and 
TestPlateResultsAnalysis2006b.xls (Figs. 22-29 and 34). In 
all cases, immediately after Turbo-DNase treating our 
RNAs, we dilute them 1:10 with nuclease-free water and 
place the RNAs at 4°C for safe-keeping (never -80°C); we 
never freeze our isolated RNAs before use. The CT values 
obtained from the Test Plate are entered into the 
TestPlateResultsAnalysis2006.xls file, the user then 
selects points for each target dilution study which give 
the best efficiency for each target and activates the 
appropriate pre-programmed macros which function to 
accept the user’s modifications and serve to help identify 
the optimal/useful RNA sample dilution ranges for each 
qPCR target. After the investigator has selected the 
dilution points for each qPCR target which demonstrate 
lack of qPCR inhibition, high reaction efficiency 
(generally accepted to be efficiencies between 80 and 
110%) and LOG-linear behavior, the FF2-6-001 qPCR set-
up tool quickly calculates the appropriate progressive 
dilution series for each target’s optimal sample dilution, 
optimal standard curve range and standard dilution 
series, all serial dilutions required of the Stock I solution 
and RNA samples, and all master mix/primer and probe 
amounts to complete the entire qPCR set-up. As a 
general rule, it is always wise for the investigator to 
include standard curves for each different target on 
every plate since this (in theory) allows qPCR studies to 
tolerate lower amplification efficiencies without 
unacceptably compromising relative target expression CT 
analyses. Since all samples on a plate are subjected to the 
same environment, lower efficiency target reactions 
analyzed on plates including the corresponding standard 
curves (at least 3-point standard curves indicating 
efficiencies no lower than 60%) still yield results that are 
truly reflective of relative target expression. The FF2-6-
001 qPCR set-up tool-determined dilution ranges 
additionally represent the useful standard curve dilution 
ranges for each target – within which sample unknowns 
and calibrators are specifically diluted so they will most 
likely appear between the first two standards of each 
Test-Plate-data-determined useful dilution curve for each 
different qPCR target (based on Stock I Test Plate 
analysis). A “sample aiming device” feature additionally 
allows the user to globally adjust this latter parameter as 
well (Fig. 39). The FF2-6-001 qPCR set-up tool’s 
TestPlateResultsAnalysis2006.xls and 
TestPlateResultsAnalysis2006b.xls files are also used to 
make sure that real-time qPCR signals from each target 
remain sufficiently strong at the outer (most dilute) 
region of each assay by revealing the limit of ‘signal 
exhaustibility’ for each target. This information is used to 
ensure that each sample RNA’s highest-but-useable 
dilution retains enough qPCR signal strength to allow 
them to remain useful as qPCR samples (e.g. as the most 
dilute target or housekeeper standard, etc.). The FF2-6-
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001 qPCR set-up tool saves time by automatically 
performing numerous and necessary calculations and it 
is a goal of ours to transform it into user-friendly 
software that can either be obtained on CD, or 
downloaded by visiting the link: 
http://www.dna.iastate.edu/frame_qpcr_res.html in the 
near future.  
 
MasterEntrySheet.xls user interface portion of the 
FF2-6-001 qPCR set-up tool 
 
The MasterEntrySheet.xls portion of the FF2-6-001 qPCR 
set-up tool is the main user interface wherein the 
investigator can enter RNA sample o.d.260nm and 
o.d.260nm/280nm readings and the dilution factor at which 
o.d.260nm and o.d.260nm/280nm readings were taken. This 
interface is also used to tell the FF2-6-001 qPCR set-up 
tool the method of RNA isolation, DNase treatment 
conditions, which samples will be included in the Stock I 
mixture, how much of each sample and standard are 
desired to complete the entire study, all Test Plate, 
Sample Plate and NRC (no reverse transcription control) 
Plate requirements, sample use, inter-plate calibrator and 
NTC usages (Figs. 11-17 and 20). The Stock I dilution 
profile for the Test Plate can also be adjusted to more 
fully interrogate the signal dynamics of any RNA or 
cDNA dilution range of interest, but, in order to save on 
precious RNA or cDNA samples, we suggest using the 
default file settings for Test Plate runs in the vast 
majority of all real-time qPCR situations. Instructions on 
how to use the FF2-6-001 qPCR set-up tool will be 
included either within the tool files themselves, or in an 
accompanying manual. The MasterEntrySheet.xls user 
interface file is connected (by equations and Visual Basic 
macros) to 22 other Excel files which make up the entire 
FF2-6-001 device. Each file is a unique tool in and of itself 
which has been carefully designed to perform numerous 
specific calculations within thousands of active cells. The 
results of one file are used by multiple other files in 
sequence to carry out extensively layered algorithms. 
Appropriate “error” messages and other reminders also 
appear within the files to inform the investigator when 
mathematically impossible demands have been entered 
into the system. The FF2-6-001 qPCR set-up tool also 
automatically identifies samples with problematically 
low RNA or cDNA concentrations and tells the user 
which samples will be expected to exhibit qPCR 
inhibition. After one global macro has been activated and 
allowed to run, Sheet 2 within the MasterEntrySheet.xls 
file provides all the printable information investigators 
will need to set-up everything for each entire qPCR 
study (Figs. 19, 22, 31-35). 
 
DISCUSSION 
 
Given the meticulous nature of real-time qPCR, it is clear 
to many who perform this technique that any time-
saving device during design and set-up is highly 
valuable (Figs. 43 and 44). Our own use of the FF2-6-001 
tool has saved incredible amounts of time during qPCR 
set-ups. The development of such a tool became an 
absolute necessity for us after frequently dealing with as 
many as sixty samples and seven qPCR targets at a time 
– for which well-rendered preliminary targets tests and 
set-up calculations often took several days. With the 
advent of liquid-handling robot technology (Fig. 45), a 
marriage between such machines and the FF2-6-001 
qPCR set-up tool would be most helpful and indeed 
welcome in the qPCR world. Addressing qPCR 
inhibition is of utmost importance toward attaining 
accurate quantitative data, and it is necessary for all 
qPCR investigators to be able to clearly demonstrate that 
they are using their qPCR samples at non-inhibitory 
concentrations (no matter what the cause of inhibition 
is). Manuscripts lacking such proof yet espousing 
accurate qPCR results should be read with caution since 
qPCR inhibition, in particular, is perhaps the most 
problematic feature of the assay, and we feel it has not 
yet been addressed as much as it really should be. We 
hope that this manuscript serves a role in that regard. As 
a case in point, what if RNA sample-related one-step 
real-time qPCR inhibition were to remain uncorrected or 
unaddressed during routine analysis for H5N1 in 
infected duck tissues for example (Fig. 46) and, what if 
studies using Northern analyses to assess gene 
expression or viral presence produced data which 
indicated a much higher fold gene expression or viral 
presence than correlate real-time qPCR studies showed? 
Such scenarios could be explained on the troubling basis 
that sample RNA (or cDNA) was not responsibly 
ascertained to be non-inhibitory to the qPCR assay itself 
beforehand. This is why it is so important to run a Test 
Plate using a mixture of some or all of the DNase-treated 
RNAs (or cDNAs) in an experiment as a Stock I RNA (or 
cDNA) solution – and test this Stock I for each target (up 
to 7 targets in our designs) in singlet (to save on master 
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mix) along a dilution profile typically ranging from 1:10-
diluted Stock I, on out to 1:1,300,000-diluted Stock I 
(which translates into a range of 1:38.46 to 1:5,000,000 
final in-well sample dilutions). Keeping track of the 
approximate nanograms of RNA or cDNA per µl for 
each sample throughout all procedures (by taking into 
account all dilutions incurred by each sample since 
original o.d.260nm readings were performed for each 
individual RNA) becomes important when trying to 
identify possible causes of observed inhibitory 
phenomena based on final in-well sample RNA or cDNA 
concentrations. In cases where one is using extremely 
small amount of total RNA in-well (e.g. as with many 
housekeeping targets), one has already eliminated 
inhibition Types 1, 2, 3 and 5 by dilution alone, but, one 
has not eliminated the possibility that sequence-specific 
interactions with specific primers and probe for each 
qPCR target could still be causal agents of inhibition (38). 
This is complex and has been discussed recently as being 
tissue-specific as well (1, 2). As yet unknown or 
unidentified causes of qPCR inhibition (i.e. “Type 6”) 
may indeed abound. 
 
CONCLUSIONS 
 
In closing, it is important to note that we have crafted the 
FF2-6-001 qPCR set-up tool to address as many features 
of qPCR as possible in order that users are able to swiftly 
attain precise qPCR set-ups specifically tailored to each 
experiment’s unique dynamics. Investigators can speed 
things along toward meaningful real-time qPCR results 
in other crucial ways as well by: 1.) using primers and 
probes that have already been optimized on cDNA and 
have been shown to be able to generate reliable, high 
efficiency dilution/calibration/standard curves days or 
weeks in advance (or one may use 1 µM primers and 150 
nM probe in all cases where primer-probe optimizations 
have not yet been performed), 2.) identifying the best, 
sample-specific RNA isolation technique which yields 
RNA isolates that exhibit the least amount of inhibitory 
phenomena during qPCR; and sticking with that method 
while bearing in mind that Trizol® isolation is still the 
cheapest way to go, 3.) running a Test Plate for all 
targets of interest using a representative sample or 
mixture of samples (e.g. Stock I), 4.) analyzing Test Plate 
results to identify the target-specific dilution ranges 
within which each different target generates a near-ideal 
slope (e.g. -3.3219) while exhibiting LOG-linear behavior, 
then, diluting all samples into these multiple ideal ranges 
so they can be used for each different target within each 
target’s confirmed useful dilution range. This not only 
improves confidence in targets being able to amplify 
within the proven useful range of their respective 
standard curves, but also ensures that inhibition of any 
variety is absent and that high fidelity reactions can be 
consistently expected – all things which the FF2-6-001 
qPCR set-up tool quickly and faithfully calculates, 5.) 
identifying, validating and using at least two reliable 
sample-specific housekeepers in each qPCR study, 6.) 
making sure all nucleic acid samples are treated 
identically before qPCR (i.e. DNase-treatment conditions, 
etc.) – including the RNA or DNA used to generate 
absolute or relative standard curves, and 7.) running 
standard curves on each and every plate for each target 
tested – never forget that it is always correct to run 
standard curves on every plate – for this way, samples 
and standards both suffer the same degree of reaction 
efficiency or inefficiency – whichever the case may be, 
thus allowing one to obtain more precise relative data. 
For fluorogenic real-time qPCR, our own bias is toward 
using the hydrolysis probe method in a one-step 
approach exclusively in all situations since it has the 
added advantage of being able to use forward and 
reverse primers to further reinforce the specificity of the 
fluorogenic probe in target amplifications by acting as 
‘rooks [primers] guarding the fidelity of the [probe] king’ 
– making doubly sure that only a highly-specific reaction 
takes place – especially in cases where one, two, or all 
three of these players can be designed to span a genomic 
intron – or introns – or other strategically advantageous 
regions. MGBNFQ probes allow even more possibilities. 
And finally, fortunately, it is the nature of PCR to 
amplify extremely small amounts of starting nucleic acid 
template material, and our studies have all benefited 
from this classic feature in that all tissue RNAs isolated 
for all studies so far (and subsequently diluted 
appropriately on a target-by-target basis to each of their 
optimal non-inhibitory, LOG-linear ranges) have 
exhibited solid target signals. We contend that all Stock I 
solutions will be useful if they are comprised of the 
experimental samples involved in each qPCR study. 
Stock I solutions in and of themselves (by virtue of them 
being composed of either portions of all the samples in a 
study, or portions of those samples most expected to 
contain all qPCR targets of interest) represent self-
mitigating/self-attenuating tools already tailored to the 
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specific confines (known and unknown) of each 
particular qPCR study. A “closed system” is formed this 
way – a system that by default is allowed to establish its 
own characteristic dynamic(s) since, by design, it uses 
the very stuff it is made of in order to study itself. 
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APPENDICES
 
Appendix 1 
 
Final, in-well dilution of sample RNA refers specifically to the dilution that each RNA sample incurs post DNase-
treatment by the time it exists in the PCR plate reaction wells. In our lab, for Turbo DNase-treating RNA, we typically 
use 60 to 80 µl of RNA sample in each 100 µl DNase-treatment reaction, which, after inactivation reagent is added, 
each become 110 µl – from which 80 µl of each final DNase-treated RNA sample is recovered. The DNase-treated 
RNAs are then immediately diluted 1:10 with nuclease-free water (Ambion) and stored at 4°C (not -80°C as commonly 
suggested). After optimal dilutions for each target (as established by FF-2-6-001-based Test Plate analyses) have been 
carried out, 7.8 µl of each optimally-diluted RNA sample is subsequently used in each final 30 µl qPCR reaction 
mixture (of which 25 µl is added to the final 96-well qPCR reaction plates). The in-well dilution of each RNA sample is 
thus 0.26 in each case. So the most concentrated RNA sample possible (post DNase-treatment, in-well) in our one-step 
real-time qPCR studies is a 1:38.46-diluted RNA sample (e.g. 0.1 [immediately post-DNase dilution factor] x 0.26 [in-well dilution factor]). But, 
this dilution is rarely useful as it consistently demonstrates severe qPCR inhibition; no amplification of target signals. 
Consequently, it is only useful as the sample on Test Plates which most clearly exhibits the stark reality of real-time 
qPCR inhibitory phenomena (possibly all five types). We routinely use all of our DNase-treated sample RNAs within 
6 months and have found most of them to be stable (stored at 4°C) for over three years as real-time qPCR templates 
(which is highly contrary to the plethora of technical literature which warns against this). We have designed the FF2-6-
001 qPCR set-up tool to keep track of all RNA sample dilutions at every step along the way throughout each entire 
qPCR procedure; from initial RNA spectrophotometer 260nm and 280nm readings on. This feature makes it possible for 
us to know the ng/µl in-well RNA concentrations for each final target qPCR reaction (see Figures 37 and 38). 
 
Appendix 2 
 
Type 4 inhibition is especially difficult to assess or identify when using commercial master mixes since such reagents 
are restrictive in that they are very rarely altered by investigators before use in qPCR. Mg2+ and dNTP concentrations, 
along with other corporately undisclosed proprietary components (including passive reference molecules such as 
“ROX”) are assumed to be “optimal” as is – as purchased from the manufacturer. But, as most conventional PCR users 
know, adjusting Mg2+ concentrations, in particular, has profound effects on the efficacy of PCR reactions in general, 
and such adjustments to commercial master mixes would undoubtedly influence the kinetics of primer-probe 
interactions with qPCR target templates. Adjusting, for instance, ABI master mix Mg2+ concentration from 7.5 mM to 
5.5 mM has been demonstrated be more appropriate for qPCR amplification of the ubiquitously-abundant 18S 
ribosomal RNA [housekeeping] transcript (34), but, in practice, most investigators find such adjustments too nebulous 
or laborious to pursue. The “high-throughput” philosophy of real-time qPCR relies heavily on the existence of 
immediately-available, ready-to-use, pre-optimized (yet notoriously expensive) reagents, and as a result, the impetus 
for investigators to manipulate [pre-made] master mix components in effort to study the finer thermodynamic details 
of primer-probe interactions with real-time qPCR target templates under different conditions (e.g. to more fully 
explore the nature of Type 4 qPCR inhibition) is diminished in many cases. The reality that many important 
proprietary components in key reagents can never be openly discussed (for fear of violating copyrights or company 
privacy policies) ultimately limits the rate at which such questions might be answered. 
 
Appendix 3 
 
Rn, or normalized reporter fluorescence, is the level of fluorescence detected during PCR. Rn is calculated by dividing 
the reporter signal by the passive internal reference dye, rhodamine-5-carboxy-X (ROX). During PCR, Rn increases as 
target nucleic acid is amplified until the reaction approaches a plateau. ROX is a proprietary passive internal reference 
dye that does not participate in the PCR reaction where the “X” in each form of ROX differs from company to 
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company (which is why ROX from different sources does not work the same). ROX emits a constant background 
fluorescent signal throughout the reaction. If there is a change in the delivered volumes of PCR Master Mix due to 
pipetting errors or sample evaporation, there will be a change in the intensity of fluorescence produced from the ROX 
molecule. e.g. if a sample has slightly evaporated – the components in the mixture are more highly concentrated and 
thus would give off more fluorescent signal per unit volume; this is true not only for ROX, but your target and 
endogenous reference reactions as well. Most quantitative PCR machines automatically correct for these changes in 
sample volume by normalizing all signals to ROX. The emission intensity of the target fluorescence signal (the target 
gene, sequence or message, or endogenous reference signal you are looking for) is divided by the emission intensity of 
ROX. Theoretically, a perfect plate would contain equal amounts of ROX in every well – but in practice, even well-
rendered/executed triplicates can show unacceptable variations in signal intensity, and if this problem is due to master 
mix addition discrepancies, ROX is used to correct for that (as well as non-PCR-related well-to-well fluctuations in 
fluorescence). ABI instruments absolutely require ROX to generate CT and Rn values correctly, while BIO-RAD 
fluorogenic real-time PCR instruments do not. In the absence of ROX, more inconsistent CT and Rn values are expected 
from the ABI GeneAmp® 5700 Sequence Detection System (according to technical support, ABI). The ability (of the 
ABI GeneAmp® 5700 Sequence Detection System) to use ROX to normalize for non-PCR-related, well-to-well 
fluctuations in fluorescence is achieved by using fluorescence readings taken at 95°C in the baseline region, and is 
apparently “essential” for reproducible results. However, the ABI GeneAmp® 5700 Sequence Detection System cannot 
differentiate between reporters, TAMRA or ROX dyes, as it uses a total reading of each well. Therefore, there is no 
normalization by ROX in the ABI GeneAmp® 5700 Sequence Detection System. “However, the background used to 
calculate the delta Rn value provides more reliable data because of ROX addition” (Justin Liao, ABI technical support). 
TAMRA-quenched probes do not require an internal reference dye; they can use TAMRA itself (in newer, post ABI 
GeneAmp® 5700 Sequence Detection System machines, i.e. ABI GeneAmp® Models 7300 and 7500). ROX, TAMRA, 
FAM, VIC etc., are all measured together on the ABI GeneAmp® 5700 Sequence Detection System; the ROX passive 
reference normalizing signal is not shown separately; only varying intensities of black and white are measured – not 
color. Since ABI master mixes contain 300 nM ROX, while Stratagene master mixes are formulated to contain 30 nM 
ROX (when ROX is used), it is important to note that investigators using ABI master mixes on Stratagene qPCR 
machines (Mx4000, Mx3000 and Mx3005P) cannot hope to use ROX as an agent for normalizing reporter fluorescence 
because the ABI ROX signal is simply too strong. This is due to the fact that different amounts [and perhaps kinds] of 
ROX are optimal for each of the two machines since a different technology is used to measure well to well 
fluorescence in Stratagene machines as opposed to the ‘halogen flood lamp’ method employed by ABI. 
 
Appendix 4 
 
It is important to note here that all reverse primer concentrations were increased by at least 200 nM in concentration 
for all one-step reactions (above what their apparent optimal concentrations were observed to be during initial two-
step optimization evaluations; but never above 1 µM). This is necessary since all reverse primers are utilized to 
unknown extents during first-strand synthesis in all one-step qPCR processes; the reverse transcription phase of such 
reactions are not primed by (i.e.) random hexamers, but instead by the sequence-specific reverse primers themselves – 
thereby limiting reverse primer presence to unknown extents during the final (PCR) phase of each target amplification 
reaction. In recent experience, we have found that boosting reverse primer concentrations (beyond what two-step 
primer-probe optimization trials initially indicated) preceding one-step qPCR analyses has improved the overall 
fidelity of all qPCR target reactions tested so far. Further, we find that using ‘saturating concentrations’ of primers (1 
µM each) and probe (150 nM) is suitable for all qPCR targets (abundant and rare), especially after responsible 
preliminary qPCR Test Plate analyses have been performed on all targets beforehand. 
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Appendix 5 
 
To protect new qPCR assays from carryover contamination by amplicons generated from prior experiments in the 
same work area, many master mixes (including several ABI master mixes) contain dUTP instead of dTTP in order to 
take advantage of an enzyme known as “UNG” which destroys all uracil-containing amplicons left over from prior 
reactions in the same qPCR work area. AmpErase® UNG (ABI) is employed largely for two-step qPCR procedures but 
not for the particular one-step qPCR procedure we use. UNG cannot be used when one-step qPCR is performed using 
the TaqMan Gold RT-PCR Kit (ABI) or the TaqMan® One-Step RT-PCR Master Mix Reagents Kit (the master mix we 
use). UNG enzyme is active at the temperatures used for reverse transcription (48°C) so it would remove uracil bases 
that are incorporated into newly synthesized complementary DNA (cDNA) strands; all nascent transcripts would be 
immediately digested by UNG as they are synthesized. The Uracil DNA-Glycosylase enzyme (UDG) also known as 
‘UNG,’ hydrolyzes uracil-glycosidic bonds on single and double stranded dU-containing DNA. Treating pipettes and 
reaction mixtures with AmpErase® UNG enzyme before each new PCR will destroy any old template containing uracil 
and therefore prevent re-amplification of carryover PCR products left over in the PCR room that may have drifted into 
new reaction tubes during set-up; in most cases, using AmpErase® UNG at 1 U/100 µl reaction is sufficient. However, 
AmpErase UNG can be used to remove prior amplicon contamination in one-step qPCR when using the TaqMan EZ 
RT-PCR Core Reagents (ABI). The rTth DNA Polymerase contained in the kit is thermally stable and is used at 
temperatures at which AmpErase® UNG is inactive. Because one-step EZ RT-PCR utilizes dUTP, amplicons generated 
during this reaction contain uridine residues. Since we cannot use UNG in our one-step master mix, we entirely avoid 
contaminating our work areas with prior amplicons by bleaching all surfaces before working, and by never pulling the 
plate cap strips off of any qPCR plates that have already been run. 
 
Appendix 6 
 
Stock I cDNA refers to a cDNA or mixture of selected cDNAs from which it is shown by preliminary, real-time qPCR 
tests to express positively for all targets of interest to the particular qPCR study at hand. The “1:5” or “1:10” dilutions 
refer to the chosen dilution of any “full-strength” Stock I cDNA whose original concentration is that which was 
obtained directly from reverse transcription reaction(s). Typical reverse transcription (or cDNA synthesis) reactions 
yield approximately 20 ng/µl cDNA when assuming each reaction to be 100% efficient. 
 
Appendix 7 
 
pH-ing RNA storage buffers to between 6.4 and 7.0 (e.g. Ambion Cat. No. 7000, 1 mM sodium citrate solution, ~pH 
6.4) helps to minimize 2’-hydroxyl base-catalyzed self-hydrolysis of RNA molecules. DNA (or cDNA) storage buffers 
are safe at pH 8.0 (e.g. Ambion Cat. No. 9849, TE pH 8.0 or Cat. No. 9856, 1 M Tris, pH 8.0).  
 
Appendix 8 
 
That less secondary structures are allowed to form on shorter freeze-fractured templates, therefore allowing the 
reverse transcription phase to happen more efficiently, though speculative, is an additional possibility [comment by 
Dr. Brett Sponseller as relayed to us by Iowa State University Research Associate, Sandra K. Clark]. 
 
Appendix 9 
 
In 2005, we assisted Invitrogen in the creation of a new master mix for use exclusively with very small RNA samples 
from cells – including LCM-derived RNA isolates used in one-step real-time qPCR. To answer questions as to whether 
or not LCM-derived RNA was stable after freeze-thawing, and whether or not directly-extracted total cellular contents 
could be used in one-step real-time qPCR applications, we were invited to help Invitrogen develop this master mix 
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based on an already-existent product line of theirs: CellsDirect™. This endeavor consisted of an effort between us and 
key Invitrogen personnel: Sharon Lahn, Ginger Lucero M.F.S. and Dr. Wolfgang Kusser, and resulted in the 
formulation of the Invitrogen product: CellsDirect™ One-Step RT-PCR Kit, Part No. 46-7201 (16, 35, and see also Fig. 
47). 
 
Appendix 10 
 
Use of pentadecamers (26) should now replace the use of random octamers (as suggested by Invitrogen) or random 
hexamers (as suggested by ABI) to prime reverse transcription reactions, especially reactions which aim to reverse 
transcribe 18S ribosomal RNA in addition to mRNA. Since 18S ribosomal RNA transcripts have no poly(A) tails (like 
histone-encoding mRNAs), it is summarily inappropriate for investigators to use poly(dT) constructs to prime reverse 
transcription reactions for it. Use of poly(dT) would not allow 18S ribosomal RNA transcripts to be effectively 
transcribed during reverse transcription (although a small amount will always be reverse transcribed into cDNA 
because of normal, expected low-level RT mis-priming events; Trish at ABI Technical Services). Further, improving 
cDNA yields from reverse transcription reactions can of course enhance qPCR detection of rare targets. Many 
companies (including Invitrogen, Stratagene and ABI) offer RT enzymes which function at temperatures above 48°C 
(i.e. from 50 up to 60°C). Higher reverse transcription temperatures serve to limit thermodynamically-favorable-yet-
troublesome formations of common secondary RNA structures (e.g. hairpin loops, hammerhead formations, sticky 
complementary regions etc.) thereby making it easier for RT enzymes to stay on RNA transcripts longer in order to 
produce fuller-length cDNAs. ‘RNase H status’ of each different RT enzyme is also a feature which companies alter 
according to needs of investigators. The RNase H activity of RT enzymes functions to degrade sample RNA as soon as 
it is used as template for cDNA synthesis. But, since most qPCR amplicons average 100 bp, while an RNase H-RT 
enzyme (an RT enzyme lacking RNase H activity) can provide an advantage when synthesizing long cDNA products, 
it does not provide a similar advantage for the shorter amplicon regions such as those amplified by real-time qPCR. In 
fact, RNase H-RT can limit the sensitivity of qPCR detection. If RNA template is not degraded after first-strand cDNA 
synthesis, it can complementarily bind to the newly-synthesized cDNA and restrict its accessibility to complementary 
primers and probes during subsequent PCR amplification. RNase H+ mediated destruction of template RNA can 
prevent this problem and improve the sensitivity of qPCR analysis. On another front, Promega corporation reminds 
us that adding more units (U) of RT enzyme per unit volume reverse transcription reaction allows the reactions to be 
skewed in favor of reverse transcribing ‘mRNAs’ instead of the normally, dominantly-transcribed, 18S ribosomal 
RNA. Rarer targets can be more efficiently reverse transcribed into cDNA this way; Promega technical notes suggest 
the use of 3.125 U/µl for reverse transcription instead of 1.25 U/µl in this regard. Finally, it is important to keep in 
mind that any tampering with RNA isolates (including linear amplification, method of reverse transcription, freeze-
thawing, etc.) always invites the risk of skewing original RNA profiles away from what they originally were. And this, 
in turn, can greatly affect real-time qPCR results. 
 
Appendix 11 
 
A little-known tertiary dynamic of qPCR is that normalization of target values by endogenous housekeeper values is 
most precise when the CT values for both appear within the same cycle range (Trish, ABI technical support). In other 
words, sample RNA and cDNA, when used to assess endogenous housekeeping transcripts by qPCR, should be 
diluted such that the resulting amplifications cross threshold (generate CT values) within the same region that the 
target amplifications do. The hyper-abundant endogenous housekeeper, 18S ribosomal RNA, often requires sample 
RNA or cDNA dilutions of 1:4,000 or higher (up to 1:10,000) before its CT values appear within (or at least much 
nearer) most other target CT ranges. Reducing amount of probe (and sometimes primers) for such strong signals 
reduces the voracity at which they amplify (a common practice in multiplex qPCR to prevent robustly-expressed 
target amplifications from exhausting master mix dNTPs before less abundant target transcript amplifications are able 
to use them) and provides another way for single-plex real-time qPCR users to influence CT values of any target or 
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housekeeper. By reducing the amplification efficiency (E) of certain target or housekeeper amplifications (e.g. by 
limiting probe amounts) so that they yield CT values more in keeping with other target or housekeeper CT values, one 
theoretically obtains better relative quantitative qPCR data. 
 
Appendix 12 
 
Given the following assumptions that:  1.) typical eukaryotic cells contain about 20 pg of total RNA, that 2.) 83% of 
total cellular RNA is ribosomal RNA (28S, 18S, 5.8S and 5S rRNA), 15% is transfer (tRNA), 2% is messenger RNA 
(mRNA), that 3.) 24% of all rRNA is 18S rRNA, that 4.) the average eukaryotic mRNA size is ~2000 bases, and that 5.) 
the average nucleotide MW = 330 g/mole, one can calculate (using Avagadro’s number as 6.02214199 x 1023 
transcripts/mole) that there are roughly 360,000 total mRNA transcripts per cell at any given moment. Further, if one 
assumes that ~25,000 differently-encoded mRNAs co-exist at any time, one can calculate that there are about 105.4 more 
18S rRNA transcripts present than there are of any specific type of target mRNA (using a MW of 624 kDa for the 
human 18S rRNA transcript based on NCBI Accession #M10098). This clearly explains why 18S rRNA often generates 
real-time qPCR CT values up to 18 cycles earlier than most other mRNA targets, and why RNA samples must be 
diluted so extensively in order to measure 18S RNA signal appropriately by qPCR. Other endogenous redundantly-
copied housekeeping genes also exhibit relatively earlier-appearing CT values, but none so dramatic as 18S rRNA. 
 
Appendix 13 
 
The representative RNA to be used as template on the Test Plate should be a mixture of only those sample RNAs in 
any given experiment which are reasonably expected to contain all the real-time targets of interest in the study. 
Including RNA samples which are not expected to contain one or all of the targets of interest serve only to dilute the 
RNA mixture away from its usefulness on the Test Plate. Using a mixture of the experimental (1:10 pre-diluted) RNAs 
themselves also controls for RNA sample preparation within the experiment itself – eliminating errors that can be 
introduced by using an experimentally exogenous source of Test Plate or standard curve RNA prepared differently 
from the way the experimental sample RNAs have been. We have found it to be extremely imperative that one use a 
mixture of the experimental sample RNAs themselves not only as template for the Test Plate, but also as the source of 
template from which all standard curves and inter-plate calibrators (inter-plate calibrators we use as an extra standard 
sample or as a sample placed on multiple plates in order to ascertain the fidelity of amplification among multiple 
plates in cases where data from one plate is to be compared with data from another) for the entire experiment are 
prepared. This illustrates the critical need for one to think ahead during extensive qPCR studies in order that one does 
not run short on such important template mixtures at some unforeseen point (the FF2-6-001 qPCR set-up tool 
calculates this parameter as well). We call such RNA mixtures “Stock I.” Our typical Stock I RNA solutions vary in 
size from 600 µl to 1,500 µl depending on how many Test Plates, final qPCR sample plates (using standard curves and 
inter-plate calibrators), and NRC plates each study requires. We strongly advise investigators to create drawings of all 
the plates to be run in each qPCR study and use them to manually confirm how much Stock I RNA (or cDNA) and 
how much of each sample RNA (or cDNA) will be needed. These values are also calculated by the FF2-6-001 qPCR set-
up tool, but it is always good for the investigator to cross-corroborate these calculations since it is easy for users to 
unknowingly introduce logistical mistakes during extensive qPCR set-ups. 
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Appendix 14 
 
Table 1: Successful primer and TaqMan® probe designs. Primer-probe sets which have yielded favorable qPCR amplifications using parameters 
identified by the FF2-6-001 qPCR set-up tool invention. 6FAM or VIC = 5’ Fluorescent reporter dye, TAMRA = 3’ Fluorescent quencher dye. 
MGBNFQ = 3’ Minor groove binding non-fluorescent quencher. 
Ovine (Ovis aries) studies: Caverly-Grubor-Derscheid-Meyerholz-Lazic-Olivier-Gallup-Ackermann 
SBD-1 Fwd primer: 5ʹ-CCATAGGAATAAAGGCGTCTGTG 
Rev primer: 5ʹ-CGCGACAGGTGCCAATCT 
Probe: 5ʹ-6FAM-CCGAGCAGGTGCCCTAGACACATGA-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#U75250 
ovTTF-1 Fwd  primer: 5’-TCCCAGGCGCAGGTGTAT 
Rev  primer: 5’-CGGACAGGTACTTCTGCTGCTT 
Probe: 5’-6FAM- AGCTGGAGCGACGCT-MGBNFQ 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#DQ010920 
ovSP-A Fwd  primer: 5’-TGACCCTTATGCTCCTCTGGAT 
Rev  primer: 5’-GGGCTTCCAAGACAAACTTCCT 
Probe: 5’-6FAM-TGGCTTCTGGCCTCGAGTGCG-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#AF076633 
ovSP-D Fwd  primer: 5’-ACGTTCTGCAGCTGAGAAT 
Rev  primer: 5’-TCGGTCATGCTCAGGAAAGC 
Probe: 5’-6FAM-TTGACTCAGCTGGCCACAGCCCAGAACA-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#AJ133002 
ovICAM-1 Fwd  primer: 5’-CAAGGGCTGGAACTCTTCCA 
Rev  primer: 5’-GGTCGATGGCAGGACATAGG 
Probe: 5’-6FAM-CACCTCAGCCCCCAGGAAGCTCC-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#NM001009731 
SMAP29 Fwd  primer: 5’- GGCCCAACTGTTCTCCGAAT 
Rev  primer: 5’- GCAGACCCTTAGGACTCTTTCCT 
Probe: 5’-6FAM-ATCAGAATAGCTGGGTGAATTGTGGGCC-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#L46854 
ovRPS15 Fwd primer: 5’-CGAGATGGTGGGCAGCAT 
Rev primer: 5’-GCTTGATTTCCACCTGGTTGA 
Probe: 5’-VIC-CCGGCGTCTACAACGGCAAGACC-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 on a sequence 
given to us courtesy of Dr. Sean W. Limesand, Dept. of Pediatrics, Univ. of 
Colorado Health Sciences Center, Perinatal Research Center, PO Box 6508, 
F441, Aurora, CO (16, 19) 
*hRIBO18S Fwd primer: 5’-CGGCTACCACATCCAAGGAA 
Rev primer: 5’-GCTGGAATTACCGCGGCT          
 
Probe: 5’-VIC-TGCTGGCACCAGACTTGCCCTC-TAMRA Designed by 
ABI using accession #XO3205  
*This primer-probe set is a theoretically faulty thermodynamic design, but 
it still works very well. See reference (34) for more information. 
bRSV Fwd primer: 5’- CAGTCAAGAATATTATGCTTGGTCATG 
Rev  primer: 5’-CCTAACTTTTGTGCATATTCATAGACTTC 
Probe: 5’-6FAM-CAACCTGTTCCATTTCTGCTTGTACGCTG-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#NC_001989 
hRPS15 Fwd primer: 5’-CCTTCAACCAGGTGGAGATCA 
Rev primer: 5’-CATGCTTTACGGGCTTGTAGGT         
Probe: 5’-VIC-CCGAGATGATCGGCCACTACCTGG-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#BC105810 
Equine (Equis caballus) studies: (Clark-Sponseller) 
Equine IL-
10 
Fwd primer: 5-GATCTCCCAAATCCCATCCA    
Rev primer: 5ʹ-AGGAGAGAGGTACCACAGGGTTT 
Probe: 5ʹ-6FAM-CCAAGGAGCTGATTCAGCTCTCCCAGAA-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#U38200 
Equine IL-
12 p40 
 
Fwd  primer: 5’-GGCCAGATCCGTGTCCAA 
Rev  primer: 5’-GGATACGGATGCCCATTCG  
Probe: 5’-6FAM-CCAGGGACCGCTACTACAGCTCATCCT-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#Y11129 
Equine 
GA3PDH 
Fwd  primer: 5’-CCCACCCCTAACGTGTCAGT 
Rev  primer: 5’-TCTCATCGTATTTGGCAGCTTTC 
Probe: 5’-6FAM-TGGATCTGACCTGCCGCCTGG-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#AF157626 
Chicken (Gallus gallus) studies: (Brockus-Harmon-Gallup-Ackermann) 
Gallinacin 
1 
Fwd primer: 5’- GGAAGGAAGTCAGATTGTTTTCGA 
Rev primer: 5’-GAGCATTTCCCACTGATGAGAGT    
Probe: 5’-6FAM-AGAGTGGCTTCTGTGCATTTCTGAAGTGC-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#AF033335 
Gallinacin 
2 
Fwd primer: 5’-GGAGGGTCCTGCCACTTTG 
Rev primer: 5’-CGGAACCCGAAGCAGCTT 
Probe: 5’-6FAM-AGGGTGTCCCAGCCATCTAATCAA-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession # 
AF033336 
Chicken 
18S rRNA 
Fwd primer: 5’- CCATGGTGACCACGGGTAAC 
Rev primer: 5’-GGATGTGGTAGCCGTTTCTCA             
Probe: 5’-VIC-CCCTCTCCGGAATCGAACCCTGATT-TAMRA 
Designed by us using ABI Prism Primer Express™ v2.0 and accession 
#AF173612 
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FIGURES 
 
 
Fig. 1: qPCR amplification of 18S ribosomal RNA using Trizol®-isolated RNA from H441 cells (with 1.8-2.0 RNA purity ratios observed) appear to 
demonstrate inhibition Types 1, 2 and 3 with the 1:38.46 dilution and inhibition Types 1 (and presumably 4) with the 1:200 and 1:400 dilutions shown 
here. Trizol® was used for RNA isolation from H441 cells (1.8-2.0 RNA purity ratios observed). Whole lung tissue total RNA isolates show the same 
sample-related inhibition threshold for 18S ribosomal RNA to be ~ 1:4,000 as well – and this is seen commonly with the hyper-abundantly expressed 
target, ribosomal 18S RNA when sample RNA has been isolated using Trizol®. 
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Fig. 2: Housekeeper hRPS15 amplifications using Trizol®-isolated RNA from H441 cells (with 1.8-2.0 RNA purity ratios observed) appear to demonstrate 
inhibition Types 1, 2 and 3 with the 1:38.46 dilution shown here. Whole lung tissue total RNA isolates show the same sample-related inhibition threshold 
to be ~1:200 as well – and this is seen with most intermediately-abundant targets when sample RNA has been isolated using Trizol®. Human ribosomal 
protein S15 (hRPS15) primers and probe were used here at 1 µM and 150 nM, respectively. 
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Fig. 3: (Marligen) column-isolated/purified RNA exhibits a lower threshold of qPCR inhibition. Inhibition Types 1, 2 and 3 are presumably demonstrated 
with the first dilution point shown here. Marligen Rapid Total RNA Purification System RNA isolation from equine dendritic cells: inhibitory phenomena 
are not apparent beyond a dilution of 1:50 using RNA isolated by this method. Rare qPCR targets often exhibit lower amplification efficiencies. 
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Fig. 4: (Marligen) column-isolated/purified RNA exhibits a lower threshold of qPCR inhibition. Inhibition Types 1, 2 and 3 are presumably demonstrated 
with the first dilution point again shown here. Marligen Rapid Total RNA Purification System RNA isolation from equine dendritic cells: inhibition is slightly 
apparent beyond a dilution of 1:50 using RNA isolated by this method; an amplification efficiency of 133.08% here indicates possibly lingering inhibition 
of the first point(s) of the apparent optimal standard curve RNA sample dilution region for equine IL-12p40. However, since singlet samples were run 
here, this observation is useful as a warning only to a certain extent; successful, uninhibited qPCR was carried out for this target using the RNA dilution 
range selected here. 
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Fig. 5: Demonstration of typical inhibitory qPCR profiles exhibited on qPCR Test Plates by the more concentrated RNA samples (on the right hand side of 
each graph) in a progressive dilution series. Targets here were Gallus gallus Gallinacin 1, Gallinacin 2 and Gallus gallus 18S ribosomal RNA (the single 
housekeeper). Stock I here was an equivolumetric mixture of the 26 total tissue RNA samples used in this study: just after their isolation by Trizol 
method, each RNA pellet was resolubilized in 150 µl of 0.1 mM EDTA pH 6.75, warmed to 65°C for 5 minutes, and their 260nm and 260nm/280nm 
measurements at 1:50 were taken. 70 µl of each resolubilized RNA was then Turbo-DNAse treated [70 µl RNA isolate + 10 µl 10X Turbo DNase Buffer + 
20 µl Turbo DNase enzyme (40 Units); and finally 10 µl Inactivation Reagent] and 80 µl of each was then diluted 1:10 with nuclease-free water. 
Subsequently, 50 µl of each of these 1:10 RNA isolates was mixed together into a single tube attaining a final volume of 1,300 µl. This was the Stock I 
RNA solution from which all standards and inter-plate calibrators were prepared. It was also the mixture which served as the source of the serially-diluted 
template samples for the Test Plate which we ran early on to identify the best RNA dilution ranges for each of the 3 targets. All calculations for this study 
were quickly performed by the FF2-6-001 qPCR set-up tool. 
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Fig. 6: Typical results obtained using FF2-6-001 qPCR set-up tool which first calculated the Test Plate set-up, then processed the Test Plate data for 
Gallinacin 1 (G1), Gallinacin 2 (G2), and Gallus gallus ribosomal 18S RNA (used as the housekeeping gene) and, in turn, the FF2-6-001 qPCR set-up tool 
additionally used that information to calculate the optimal dynamic set-up for each target on each of the final qPCR experimental plates (including 
sample RNA dilutions for each target, inter-plate calibrator dilutions of Stock I for each target, dilutions of Stock I to create all the standards for each 
target, and all master mix calculations for all Sample Plates and an NRC Plate). Notice how all unknowns fell within the trustworthy portion of the 
standard curves for G1 and its corresponding ribosomal 18S RNA housekeeper. The same was found for G2 and its corresponding ribosomal 18S RNA 
housekeeper (graphs not shown). NRC results from this study showed that all contaminating (genomic DNA) target signals were greater than 14 cycles 
away from the genuine housekeeper CT values – presenting no consequence whatsoever during data analysis. The fact that 14 different tissue types were 
used in this study speaks well for the ability of the FF2-6-001 qPCR set-up tool to be able to work with and solve for a variety of potentially variant qPCR-
inhibitory features from a myriad of tissue types. 26 total normal tissues were evaluated here; 13 from a male chicken and 13 from a female chicken: 
bone marrow, jejunum, crop, testes (male chicken) oviduct (female chicken), lung, skin, spleen, liver, kidney, bursa, trachea, conjunctiva and tongue. 
After identifying the optimal RNA dilution ranges for each target, fluorogenic real-time one-step qPCR was successfully carried out under absolutely LOG-
linear conditions exhibiting virtually 100% efficiency for each target in the total absence of inhibition of any variety using saturating concentrations of 
primers (1 µM) and probes (150 nM) for all three targets (Brockus-Harmon-Gallup-Ackermann, 2005 unpublished). 
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Fig. 7: The TaqMan® 5’ exonuclease assay. In addition to two conventional PCR primers, P1 and P2, which are specific for the target sequence, a third 
primer, P3 (called the ‘probe’), is designed to bind specifically to a site on the target sequence downstream of the forward primer binding site. The probe 
is labelled with two fluorophores, a reporter dye (R) is attached at the 5’ end while a quencher dye (D), which has a different emission wavelength to the 
reporter dye, is attached at its 3’ end. Because the 3’ end is blocked, the probe cannot by itself prime any new DNA synthesis. During the PCR reaction, 
Taq DNA polymerase synthesizes a new DNA strand primed by the forward primer, and as the enzyme approaches the probe, its 5’ to 3’ exonuclease 
activity progressively degrades the probe from its 5’ end. The end result is that the nascent DNA strand extends beyond the probe binding site and the 
reporter and quencher dyes are no longer bound to the same molecule. As the reporter dye is no longer in close proximity to the quencher, the resulting 
increase in reporter emission intensity becomes easily detectable. This all occurs in “real time” as monitored by the photomultiplier tube(s) in the 
instrument. 
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Fig. 8: Different approaches to fluorogenic qPCR; we use the highlighted TaqMan® hydrolysis probe-based real-time qPCR method. All primers and probes 
are optimized and validated according to ABI procedural guidelines (31) using all-target-inclusive (Stock I) cDNA prepared from Turbo DNase-treated total 
RNA isolated (using Trizol®) from whole tissue homogenates as described previously (17-20). Our optimization approach is a very common/well-known 
procedure whereby one first studies different combinations of primer concentrations in the range of 50 nM-900 nM while keeping the probe at a constant 
200 or 225 nM, after which the probe is studied by challenging it from 25 nM to 225 nM while primers are used at their optimal concentrations. All 
samples are performed in triplicate or quadruplicate during these evaluations to bolster significance of final evaluations. After optimization, a ‘validation 
plate’ or Test Plate is performed on up to eleven serial dilutions of the same cDNA or RNA (starting with full-strength cDNA or RNA which is assigned a 
relative dilution strength value of “1”) using the optimal primer and probe concentrations established during optimization for each target. The highest Rn 
(normalized reporter fluorescence) value achieved using the lowest primer concentrations is the indicator by which one selects the appropriate optimal 
primer concentrations in each case; the higher the Rn, the higher the magnitude of real-time fluorescent signal. Once the Rn value no longer increases 
with increasing primer concentrations, one has effectively attained the useful optimal primer concentrations. CT values (not Rn values) are evaluated 
during probe optimizations, and the lowest CT (threshold cycle) value with the lowest probe concentration is the criteria by which one chooses optimal 
probe concentrations. Once CT values no longer decrease with increasing probe concentration, one has effectively attained the useful optimal probe 
concentration. Little known is the fact that most real-time target signals can be found with greater than 75% amplification efficiency simply using 
‘saturating concentrations’ of primers (1 µM) and probes (150 nM) in most experimental situations if optimal RNA dilution ranges are established for 
each target and inhibition is entirely avoided (unpublished multiple observations from our lab, 2001-2006). 
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Fig. 9:  Example of the consistency of data generated under favorable/optimal conditions by qPCR (compare this to the results shown in Fig. 10). ABI Cat. 
No. 4309169, TaqMan® One-Step RT-PCR Master Mix Reagents Kit and the ABI GeneAmp® 5700 Sequence Detection System were used. 
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Fig. 10:  Amplification plots of the same samples (as in Fig. 9 above) run on a Stratagene Mx3005P real-time qPCR machine. Note the consistency in 
relative CT values between results from the two different machines referred to in Figure 9 and this Figure. This bodes very well for highly-optimized qPCR 
in general. ABI Cat. No. 4309169, TaqMan® One-Step RT-PCR Master Mix Reagents Kit was used. 
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Fig. 11: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 1) which the user fills out to tell the system target and housekeeper 
names and what concentrations of primers and probes will be used for each different target. Extra room is provided here (and elsewhere in the 
MasterEntrySheet.xls file) for additional targets. 
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Sample o.d. 260nm 260/280 Used in Stock I? (used)
1 0.2240 1.8600 x 0.2240
2 0.3400 1.7700 x 0.3400
3 0.2880 1.8300 x 0.2880
4 0.1150 1.6670 x 0.1150
5 0.1560 1.8900 x 0.1560
6 0.1780 1.8320 x 0.1780
7 0.1977 1.7000 x 0.1977
8 0.2440 1.9700 x 0.2440
9 0.4217 1.9980 x 0.4217
10 0.2009 2.0100 x 0.2009
11 0.3169 1.7500 x 0.3169
12 0.2649 1.7330 x 0.2649
13 0.2300 1.6780 x 0.2300
14 0.1329 1.7230 x 0.1329
15 0.1549 1.7750 x 0.1549  
Fig. 12: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 1) where the user enters all sample o.d.260nm readings and selects 
(using an “x”) which samples are to be used in the creating the Stock I solution for the entire study  (this data entry region extends to 72 samples; only a 
15-sample portion is shown here). 
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72 Stock I parts Stock I calculated o.d. 260nm and ng/uL
25.00 uL from each part 0.0135 26.923 ng/uL
Spec 260/280 readings taken initially at 1: 50 1
Stock I made Stock I left after the Test Plate run Stock I left after Sample & NRC Plates
1800 uL Focus-Field Tool-1 1553 uL Focus-Field Tool-1 49 uL
Other Stock I OK
used or lost? OK
0 uL Final safe amount of each RNA/target dilution needed:
Focus-Field Tool-1 adjust here: 350 uL 0 problem samples
Total final DNase rxn volumes: 110 uL RNA isolation
Amount of RNA DNase treated: 70.00 uL (Trizol, Column, LCM)
Amount recovered: 80 uL (post DNase) Trizol
PostDNase Stock I parts prediluted 1: 10 Not enough RNA in
PostDNase Unknowns also prediluted 1: 10 0
p For Final Sample Plates (wells per target): 156
Rxn vol. prepared Above & below adjust 0 # of Samples: 72
30.00 uL 5.00% Points in standard curves: 4
RNA added Portion used Repeats of Target stnd.crvs.: 1
7.80 uL NTCs used per target: 1
Used in wells Inter-Plate Calibrator?: 1
25.00 uL Fine Sample Adjust: 0
# of samples For Final NRC Plates (wells per target): 77
with degrees Samples tested for gDNA by NRC: 77
of inhibition NTCs tested?: 0
0 Final Standard & IP-Calibrator volumes made: 3000 uL
Rough amount of each RNA left after used for Stock I etc. ~729 uL
   Your One-Step MM Tier 1 target ng/uL starts at: 0.53847
Parameter Adjustments:    Enter [two-step qPCR]-determined optimal
 (Based initially on ABI  primer and probe concentrations (if known)
  One-Step Master Mix) Fwd primer Rev primer Probe
MM 2.0X 300 900 150
RT solution: 40X
              Important Message: 300 300 50
ALL IS OK 300 300 100
Ctrl Shift X Reset File
Ctrl Shift Q Test Plate
Ctrl Shift M Final Plates
Limiting o.d.260nm: 0.0846
x ABI 1-STEP
ABI 2-STEP
Eppendorf 1-STEP
Eppendorf 2-STEP
Stratagene 1-STEP
Stratagene 2-STEP
Approx. cost: $3,277.07
How many reaction plates?
42
samples
Ctrl Shift X Reset
Ctrl Shift Q Test Plate
Ctrl Shift M Final Plates
Focus-Field Universal 
qPCR Set-Up Tool Pilot 
Version 1.0
Ctrl Shift Z Run X-Q-M
Ctrl Shift K resets 
Focus-Field to its 
original state
Enter 'a' or 'p' to 
use all or part rxn
adj. # Smpls
o.d. 260nm
 
Fig. 13: Key portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 1) wherein the user enters numerous other numerically descriptive 
parameters which define the particular qPCR set-up and/or approach being pursued. 
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RNA USE TALLY AREA
Number of Plates
Per Plate: SBD-1 SMAP29 SP-D TTF-1 SP-A RIBOS15 RIBO18S
iterations
Wells used for NRC 0 0 0 0 0 1 1 15.6 uL 1 15.6 uL
Wells used for NTC N/A N/A N/A N/A N/A N/A N/A 0.0 uL 1 0.0 uL
SBD-1 SMAP29 SP-D TTF-1 SP-A RIBOS15 RIBO18S iterations
Wells used for Standard 1 3 3 3 3 3 8 8 241.8 uL 3 725.4 uL
Wells used for Interplate Calibrator 3 3 3 3 3 8 8 241.8 uL 3 725.4 uL
Wells used for Standard 2 3 3 3 3 3 8 8 241.8 uL 3 725.4 uL
Wells used for Standard 3 3 3 3 3 3 8 8 241.8 uL 3 725.4 uL
Wells used for Standard 4 3 3 3 3 3 8 8 241.8 uL 3 725.4 uL
Wells used for SBD-1 SMAP29 SP-D TTF-1 SP-A RIBOS15 RIBO18S iterations
Samples: 1 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
2 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
3 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
4 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
5 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
6 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
7 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
8 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
9 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL
10 3 3 3 3 3 3 3 163.8 uL 1 163.8 uL  
Fig. 14: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 2) wherein the file system can be used to help the user calculate how 
much of each standard, inter-plate calibrator and sample will be needed to successfully complete the entire study at hand without running out of one, 
some or all of them (only a portion of this work area is shown). 
 
 
Fig. 15: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 3) which automatically calculates the required amounts needed of all 
samples, standards and inter-plate calibrators based on what the user has already entered in the portions of the MasterEntrySheet.xls file depicted in 
Figures 12, 13, and 14. 
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  TEST PLATE PARAMETER ENTRY AREA
100 uL qPCR Target List Targets Tested iterations
Sample sizes SBD-1 Target 1 SBD-1 1
made for Test SBD-2 Target 2 SP-A 1
Plate purposes SP-A Target 3 SP-D 1
adjust SP-D Target 4 TTF-1 1
0.714285714 TNF-a Target 5 SMAP29 1
100.00 uL PCV2 Target 6 RIBOS15 1
70 uL MCP-1a Target 7 RIBO18S 1 1st Test
IL-8 Plate
TTF-1 Sample
SNAP 25 7 phantom
1 SNAP 25A f.s. actually needed 0 uL adjust
Test Plate eIL-12p35 1
Dilutions used 1: HBD-6 Test Pl.
38.4615 BPIV-3 factor adj
50 hRSV adjust: 1.3
100 hSP-D 0.91 17.40 MM adjust 2.6
200 hSPA1:A2 Extra MM OK Adjust this 5.2
500 RIBO18S adjust OK value to make 13
1000 INF-g 5.5 OK sure you have 26
5000 SMAP29 GOOD enough 130
10000 eIL-12p40 OK Master Mix 260
50000 eIL-10 1300
500000 EGA3PDH Sample reps: 1 13000
5000000 TLR4 Wells per target: 12 130000
Auto-Attenuate RIBOS15
1 bRSV
Enter "x" by the 
housekeeper(s) in 
the lavendar colored 
region to the right 
here
(the housekeeper 
that you will have to 
dilute the most to 
obtain its useful 
dilution range should 
be on the very bottom
e.g. RIBO18S)Sa f e  a mount  of            
e a c h s a mple  f or          
Te s t  Pla te ;
w he n e a c h s a mple        
is  us e d in s ingle t
Enter housekeeper(s) at the bottom of the 
list here - with the 'most abundant' 
housekeeper listed at the very bottom
Ctrl Shift K Reset Focus 
Field to Original state
 
 SAMPLE PLATE PARAMETER ENTRY AREA
qPCRTarget List Targets Tested iterations
SBD-1 SBD-1 1
SBD-2 SP-A 1
SP-A SP-D 1
SP-D TTF-1 1
TNF-a SMAP29 1
RIBOS15 PCV2 x RIBOS15 1
RIBO18S MCP-1a x RIBO18S 1
7 IL-8
TTF-1 One-Step
SNAP 25
SNAP 25A Test
eIL-12p35 Plate
Original Test HBD-6 ng/uL
Plate factors: BPIV-3 7.0001033
1 .3 hRSV adjust: 5.3846948
2 .6 hSP-D 0.87 174.49 MM adjust 2.6923474
5 .2 hSPA1:A2 Extra MM OK Adjust this 1.3461737
1 3 RIBO18S adjust OK value to make 0.5384695
2 6 INF-g 5.5 OK sure you have 0.2692347
1 3 0 SMAP29 GOOD enough 0.0538469
2 6 0 eIL-12p40 OK Master Mix 0.0269235
1 3 0 0 eIL-10 0.0053847
1 3 0 0 0 EGA3PDH Sample reps: 2 0.0005385
1 3 0 0 0 0 TLR4 Wells per target: 156 5.385E-05
RIBOS15
bRSV
t r "x" by the 
housek eper(s) in 
the lavendar colored 
r i  t  t  ri t 
here
(t  r 
that you will have to 
dilute the most to 
obtain its useful 
dilution range should 
be on the very bo tom
e.g. RIBO18S)
Increasing order
Ctrl Shift K Reset Focus 
Field to Original state
 
   NRC PLATE PARAMETER ENTRY AREA
qPCR Target List Targets Tested iterations
2 SBD-1 0 1
SBD-2 0 1
SP-A 0 1
SP-D 0 1
TNF-a 0 1
PCV2 x RIBOS15 1
MCP-1a x RIBO18S 1
IL-8
TTF-1
SNAP 25
SNAP 25A
eIL-12p35
HBD-6
BPIV-3
hRSV adjust:
hSP-D 0.77 24.42 MM adjust
hSPA1:A2 Extra MM OK Adjust this
RIBO18S adjust OK value to make
INF-g 6 OK sure you have
SMAP29 GOOD enough
eIL-12p40 OK Master Mix
eIL-10
EGA3PDH Sample reps: 1
TLR4 Wells per target: 77
RIBOS15
bRSV
Ctrl Shift K Reset Focus 
Field to Original state
 
Fig. 16: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 1) which allows the user to define Test Plate parameters (and correct 
master mix usage), Sample Plate parameters (and correct master mix usage), and NRC Plate parameters (and correct master mix usage). 
 
 
Fig. 17: Close-up of a portion of FF2-6-001 set-up tool MasterEntrySheet.xls file (Sheet 1): Test Plate parameter adjustment area (as also shown in Fig. 
16). 
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TEST PLATE DEPICTION:
Machine Factors: 0.026 0.02 0.01 0.005 0.002 0.001 0.0002 0.0001 0.00002 0.000002 0.0000002
Scientific notation: 2.60E-02 2.00E-02 1.00E-02 5.00E-03 2.00E-03 1.00E-03 2.00E-04 1.00E-04 2.00E-05 2.00E-06 2.00E-07
1 2 3 4 5 6 7 8 9 10 11 12
A NTC 38.46 50.00 100.0 200.0 500.0 1000 5000 10000 50000 500000 5000000 SBD-1
B NTC 38.46 50.00 100.0 200.0 500.0 1000 5000 10000 50000 500000 5000000 SP-A
C NTC 38.46 50.00 100.0 200.0 500.0 1000 5000 10000 50000 500000 5000000 SP-D
D NTC 38.46 50.00 100.0 200.0 500.0 1000 5000 10000 50000 500000 5000000 TTF-1
E NTC 38.46 50.00 100.0 200.0 500.0 1000 5000 10000 50000 500000 5000000 SMAP29
F NTC 38.46 50.00 100.0 200.0 500.0 1000 5000 10000 50000 500000 5000000 RIBOS15
G NTC 38.46 50.00 100.0 200.0 500.0 1000 5000 10000 50000 500000 5000000 RIBO18S
Relative factors ng RNA/well: 175.0026 134.6174 67.30869 33.65434 13.46174 6.730869 1.346174 0.6730869 0.134617 0.013462 0.00134617
Tested concentrations to see where inhibition of any kind lets up for each different target …
Relative factors condensed: 1 0.769231 0.384615 0.192308 0.076923 0.038462 0.007692 0.0038462 0.000769 7.69E-05 7.6923E-06
Given that our Stock I Solution RNA mixture is calculated to be: 26.92347 ng/uL (composed of 1: 10
Abs. Quant. Not Used
This Test Plate dilution series thus represents the following in-well final ng/uL RNA concentrations:
Initial RNA is already at 1: 10 in well will actually be a 1: 38.46 7.0001033 ng/uL in well
After DNAse treatment: Desired final in-well test dilution 1: 50 5.3846948 ng/uL in well
samples are diluted 1: 10 Desired final in-well test dilution 1: 100 2.6923474 ng/uL in well
And samples, after further Desired final in-well test dilution 1: 200 1.3461737 ng/uL in well
dilutions, are then used in-well Desired final in-well test dilution 1: 500 0.5384695 ng/uL in well
at a proportion of: Desired final in-well test dilution 1: 1000 0.2692347 ng/uL in well  Stock I ng/ul range tested
7.80 uL sample Desired final in-well test dilution 1: 5000 0.0538469 ng/uL in well
30.00 uL well size Desired final in-well test dilution 1: 10000 0.0269235 ng/uL in well
sample fraction is thus: 0.26 Desired final in-well test dilution 1: 50000 0.0053847 ng/uL in well
Desired final in-well test dilution 1: 500000 0.0005385 ng/uL in well
Desired final in-well test dilution 1: 5000000 5.385E-05 ng/uL in well
1:
- diluted RNAs (post DNase treatment)
1:1: 1: 1: 1: 1: 1: 1: 1: 1:
1: 1:1: 1: 1: 1: 1: 1: 1: 1: 1:
1: 1:1: 1: 1: 1: 1: 1: 1: 1: 1:
1: 1:1: 1: 1: 1: 1: 1: 1: 1: 1:
1: 1:1: 1: 1: 1: 1: 1: 1: 1: 1:
1: 1:1: 1: 1: 1: 1: 1: 1: 1: 1:
1: 1:1: 1: 1: 1: 1: 1: 1: 1: 1:
 
Fig. 18: The FF2-6-001 qPCR set-up tool TestPlateDepiction.xls file – used to show the general Test Plate parameters and which is equationally linked to 
other key FF2-6-001 qPCR set-up tool files. 
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Fig. 19: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 2) which shows the automatically-calculated master mix preparations 
needed to perform the user-designed Test Plate. All master mix calculation files automatically figure in safe extra preparative amounts to safeguard the 
user from running short on final volumes or running into bubbles at the bottom of time-intensive sample preparation tubes. 
 
   
 
 
Gallup and Ackermann - Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system ‘FocusField2-6GallupqPCRSet-upTool-
001’ to attain consistently high fidelity qPCR reactions 
www.biologicalprocedures.com 
128
 
Fig. 20: Close up of the portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 1) used for adjusting final Sample Plate parameters (as 
also shown in Fig. 16). 
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Fig. 21: Close up of the portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 1) used for adjusting final NRC Plate parameters (as also 
shown in Fig. 16). 
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Tested concentrations to see where inhibition of any kind lets up for each different target …
Relative factors condensed: 1 0.7692308 0.3846154 0.1923077 0.0769231 0.0384615 0.0076923 0.0038462 0.00076923 7.6923E-05 7.69E-06
Given that our Stock I Solution RNA mixture is calculated to be: 26.923474 ng/uL (composed of 1: 10
Abs. Quant. Not Used
This Test Plate dilution series thus represents the following in-well final ng/uL RNA concentrations:
Initial RNA is already at 1: 10 in well will actually be a 1: 38.46 7.0001033 ng/uL in well
After DNAse treatment: Desired final in-well test dilution 1: 50 5.3846948 ng/uL in well
samples are diluted 1: 10 Desired final in-well test dilution 1: 100 2.6923474 ng/uL in well
And samples, after further Desired final in-well test dilution 1: 200 1.3461737 ng/uL in well
dilutions, are then used in-well Desired final in-well test dilution 1: 500 0.5384695 ng/uL in well
at a proportion of: Desired final in-well test dilution 1: 1000 0.2692347 ng/uL in well  Stock I ng/ul range tested
7.80 uL sample Desired final in-well test dilution 1: 5000 0.0538469 ng/uL in well
30.00 uL well size Desired final in-well test dilution 1: 10000 0.0269235 ng/uL in well
sample fraction is thus: 0.26 Desired final in-well test dilution 1: 50000 0.0053847 ng/uL in well
Desired final in-well test dilution 1: 500000 0.0005385 ng/uL in well
Desired final in-well test dilution 1: 5000000 5.385E-05 ng/uL in well
            COMPREHESIVE SERIAL DILUTION TABLE
(Stock I) A total made Stock I diluent to next
B 191.6 uL 147.4 uL 44.2 uL 91.6 uL
C 183.2 uL 91.6 uL 91.6 uL 83.2 uL
D 166.4 uL 83.2 uL 83.2 uL 66.4 uL
E 166.1 uL 66.4 uL 99.7 uL 66.1 uL
F 132.2 uL 66.1 uL 66.1 uL 32.2 uL
G 161.1 uL 32.2 uL 128.9 uL 61.1 uL
H 122.2 uL 61.1 uL 61.1 uL 22.2 uL
I 111.0 uL 22.2 uL 88.8 uL 11.0 uL
J 110.0 uL 11.0 uL 99.0 uL 10.0 uL
K 100.0 uL 10.0 uL 90.0 uL 0.0 uL
- diluted RNAs (post DNase treatment)
 
Fig. 22: A portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 2) showing the final automatically-calculated Test Plate parameters and 
set up for seven targets. This page is printed out and used as a guide for machine programming and Stock I sample dilutions. The term “reagent” in the 
dilution table above connotes Stock I as the solution used in the light blue-highlighted cell. 
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Fig. 23: FF2-6-001 qPCR set-up tool TestPlateResultsAnalysis2006.xls file; Test Plate final CT entry area (shown in red font). 
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Stnd. Curve
0.026 -1.585027 50 Efficiencies SBD-1 suggested "in-well"
0.02 -1.69897 50 #DIV/0! start useful stnd curve at 1: 250 250
0.01 -2 37.82 -5.53% serial 1: 4 1000
0.005 -2.30103 32.95 -13.27% Efficiency: 338.22% 0.00% (Better E) 4000
0.002 -2.69897 33.87 170.73% Correlation: -0.359 16000
0.001 -3 34.6 158.45% b = 36.618
0.0002 -3.69897 36.93 99.52% m = -1.5584
0.0001 -4 39.27 34.48%
0.00002 -4.69897 46.7 24.19% 46.7
0.000002 -5.69897 50 100.92% 50  Ctrl+Shift+B to run both files
0.0000002 -6.69897 50 #DIV/0! 50
log input Ct Make final manual adjustments of ranges Stnd. Curve
0.026 -1.585027 46 Efficiencies SP-A suggested "in-well"
0.02 -1.69897 39 -3.68% start useful stnd curve at 1: 1500 1500
0.01 -2 30 -7.41% serial 1: 5 7500
0.005 -2.30103 27 -20.63% Efficiency: 1034.45% 0.00% (Better E) 37500
0.002 -2.69897 27.86 190.22% Correlation: -0.252 187500
0.001 -3 28.76 116.01% b = 31.092
0.0002 -3.69897 31.57 77.31% m = -0.9481
0.0001 -4 32.24 181.38%
0.00002 -4.69897 34.62 96.65% 34.62
0.000002 -5.69897 38.46 82.14% 38.46
0.0000002 -6.69897 42.6 74.40% 42.6
log input Ct Stnd. Curve
0.026 -1.585027 45.01 Efficiencies SP-D suggested "in-well"
0.02 -1.69897 46.98 14.25% start useful stnd curve at 1: 1200 1200
0.01 -2 29.48 -3.88% serial 1: 4 4800
0.005 -2.30103 25.39 -15.59% Efficiency: -100.00% 104.77% (Better E) 19200
0.002 -2.69897 25.3 -100.00% Correlation: 0.046 76800
0.001 -3 26.1 137.84% b = 33.471
0.0002 -3.69897 27.28 291.15% m = 0.2149
0.0001 -4 29.06 47.61%
0.00002 -4.69897 31.53 91.86% 31.53
0.000002 -5.69897 35.11 90.25% 35.11
0.0000002 -6.69897 38.76 87.92% 38.76
log input Ct Stnd. Curve
0.026 -1.585027 29.64 Efficiencies TTF-1 suggested "in-well"
0.02 -1.69897 28.73 -25.05% start useful stnd curve at 1: 1500 1500
0.01 -2 22.18 -10.04% serial 1: 4 6000
0.005 -2.30103 19.8 -25.27% Efficiency: 468.74% 0.00% (Better E) 24000
0.002 -2.69897 20 9665.63% Correlation: -0.494 96000
0.001 -3 22 41.42% b = 20.660
0.0002 -3.69897 22.32 15185.56% m = -1.3247
0.0001 -4 23.9 55.07%
0.00002 -4.69897 26.22 100.12% 26.22
0.000002 -5.69897 29.7 93.80% 29.7
0.0000002 -6.69897 33.21 92.71% 33.21
Apparent good Stnd Curve
y = -0.9481x + 31.092
R2 = 0.0634
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Fig. 24: A portion of FF2-6-001 qPCR set-up tool TestPlateResultsAnalysis2006.xls file just after Test Plate CT values have been entered and preliminary 
macros have been run. Notice how the regions of qPCR inhibition are clearly exposed for each qPCR target at the right hand side of each target’s dilution 
profile (LOG10 of Stock I dilution vs. CT) graph. The most concentrated RNA samples in each case are the samples which exhibit the most qPCR inhibitory 
phenomena. 
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Stnd. Curve
SBD-1 suggested "in-well"
start useful stnd curve at 1: 250 250
serial 1: 4 1000
Efficiency: 109.76% 0.00% (Better E) 4000
Correlation: -0.998 16000
b = 25.397
m = -3.1082
 Ctrl+Shift+B to run both files
Make final manual adjustments of ranges Stnd. Curve
SP-A suggested "in-well"
start useful stnd curve at 1: 1500 1500
serial 1: 5 7500
Efficiency: 96.29% 107.51% (Better E) 37500
Correlation: -0.998 187500
b = 18.745
m = -3.4142
Stnd. Curve
SP-D suggested "in-well"
start useful stnd curve at 1: 1200 1200
serial 1: 4 4800
Efficiency: 97.79% 110.11% (Better E) 19200
Correlation: -0.999 76800
b = 15.900
m = -3.3760
Stnd. Curve
TTF-1 suggested "in-well"
start useful stnd curve at 1: 1500 1500
serial 1: 4 6000
Efficiency: 100.24% 115.57% (Better E) 24000
Correlation: -0.999 96000
b = 10.824
m = -3.3162
Apparent good Stnd Curve
y = -3.4142x + 18.745
R2 = 0.9966
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Fig. 25: Optimal ranges identified for all targets using the FF2-6-001 qPCR set-up tool TestPlateResultsAnalysis2006.xls file (which is connected by Visual 
Basic macros and equations to its “twin” file, TestPlateResultsAnalysis2006b.xls, which is used to fine-tune the parameters revealed by this file). 
Efficiencies and slopes for each target are calculated from Test Plate CT values for each qPCR target as the user manually selects different points on 
each graph in effort to ascertain the optimal RNA dilution ranges for each target. 
 
log input Ct Stnd. Curve
0.002 -2.69897 22 Efficiencies SMAP29 suggested "in-well"
0.0002 -3.69897 24.64 139.21% start useful stnd curve at 1: 1300 1300
0.0001 -4 25.43 140.46% serial 1: 3 3900
0.00002 -4.69897 28.15 80.71% 28.15 Efficiency: 100.95% 113.89% (Better E) 11700
0.000002 -5.69897 31.5 98.84% 31.5 Correlation: -0.998 35100
0.0000002 -6.69897 34.92 96.06% 34.92 b = 12.654
#VALUE! m = -3.2995
#VALUE!
#VALUE!
#VALUE!
#VALUE!
Apparent good Stnd Curve
y = -3.2995x + 12.654
R2 = 0.9961
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Fig. 26: Close up of a region of the FF2-6-001 qPCR set-up tool TestPlateAnalysis2006.xls file which is used to detect qPCR inhibition, dial in a target’s 
optimal RNA dilution range, and find the Stock I RNA dilution range which yields the highest efficiency reaction for each qPCR target. Here, qPCR target 
SMAP29 has been assessed. 
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Fig. 27: Additional example of optimal ranges identified for a different group of qPCR targets. Again, reaction efficiencies (or ‘efficacies’) and slopes were 
calculated from Test Plate CT values for each qPCR target dilution to ascertain the optimal RNA dilution ranges for each of the targets. (Early prototype 
versions of FF2-6-001 qPCR set-up tool TestPlateResultsAnalysis2006.xls and TestPlateResultsAnalysis2006b.xls files were used to make the 
determinations shown here). 
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Fig. 28: Depiction of a six-target Test Plate profile. After running the plate, the CT results are fed into FF2-6-001 qPCR set-up tool 
TestPlateResultsAnalysis2006.xls and TestPlateResultsAnalysis2006b.xls files to identify the dilution ranges for each target which allow each target to 
amplify with desirable efficiency undaunted by inhibition of any kind. A slope of -3.3219 or (-1/LOG102) represents 100% efficiency when CT values are 
plotted against the LOG10 of template input dilution factors. In our approach, CT values are generated from a standard set of eleven serial progressive 
dilutions of Stock I resulting in ‘dilution,’ ‘calibration’ or ‘standard’ curves for each target. Analyzing Test Plate CT values allows the investigator to identify 
the RNA sample dilution ranges for each target within which each target remains uninfluenced by inhibitory phenomena and is allowed to achieve 
acceptable amplification reaction efficiency somewhere along the RNA dilution profile. Dilution curve slopes ranging from -4.11 to -3.01 (or a reaction 
efficiency range of 75 to 115%, respectively) are considered to be acceptable in most real-time qPCR assays. The Test Plate-attained slopes for the above 
six targets are shown in Figure 27. 
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Fig. 29: Portion of the FF2-6-001 qPCR set-up tool TestPlateResultsAnalysis2006b file which the user can manually adjust to determine how far above 
and below the proven LOG-linear range one wishes the standard curve for each target to include. The file default is set at 20% above and 20% below the 
highest and lowest points of the proven target LOG-linear range in each case. User-access to this parameter is useful in cases where one is confident that 
the qPCR targets studied exhibit linearity further than the default 20% above and 20% below the calculated optimal dilution profile/range for each 
target. Elongation of the dynamic range of qPCR target standard curves serves to provide more room within which sample unknowns can appear and 
therefore be assessed with greater confidence. 
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Fig. 30: Portion of the FF2-6-001 qPCR set-up tool TestPlateResultsAnalysis2006b file which allows the user to fine-tune the parameters already 
established by “twin” file TestPlateResultsAnalysis2006. In this file, the user manually adjusts standard curve dilution factors, standard curve start and 
end points (or chooses to accept file default calculations for those parameters), and activates pre-programmed macros to quickly hone in on the final 
optimal RNA dilution range to be used for each target – all of which exhibit LOG-linear behavior, lack of qPCR inhibition and high amplification reaction 
efficiencies; all based on Test Plate CT analyses. 
 
SBD-1 SMAP29 SP-D TTF-1 SP-A RIBOS15 RIBO18S
Sample 1:10 RNA Water 1st total from previous Water from previous Water from previous Water from previous Water from previous Water from previous Water
1 45.8 uL 584.71 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
2 30.2 uL 600.34 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
3 35.6 uL 594.89 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
4 89.2 uL 541.30 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
5 65.8 uL 564.74 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
6 57.6 uL 572.87 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
7 51.9 uL 578.62 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
8 42.0 uL 588.46 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
9 24.3 uL 606.18 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
10 51.1 uL 579.44 uL 631 uL 280.51 uL 982.73 uL 913.25 uL 60.16 uL 623.41 uL 155.85 uL 429.26 uL 50.67 uL 129.93 uL 360.07 uL 140.00 uL 210.00 uL
Tier 1 Tier 2 Tier 3 Tier 4 Tier 5 Tier 6 Tier 7
Fig. 31: Portion of the FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 2) which shows the automatically-calculated serial dilutions the user 
will perform to obtain the appropriately and differentially diluted RNA samples that have already been calculated to be optimal for each qPCR target 
(seventy-two RNA samples are shown here). Notice how (after the Tier 1 dilutions have been performed) all subsequent sample volume transfers from 
row to row are repetitive and therefore directly amenable to liquid-handling robot technologies (see Fig. 45). 
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optimal for Target 1 optimal for Target 2 optimal for Target 3 optimal for Target 4 optimal for Target 5 optimal for Target 6 optimal for Target 7
Sample SBD-1 SMAP29 SP-D TTF-1 SP-A RIBOS15 RIBO18S
1 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
2 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
3 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
4 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
5 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
6 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
7 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
8 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
9 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL
10 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL 350.00 uL  
Fig. 32: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 2) which confirms for the user how much of each RNA dilution will be 
prepared for each optimal dilution range for each target investigated. 
 
 
Fig. 33: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 2) which shows the automatically-calculated master mix set-ups for all 
final target Sample Plates. ABI Cat. No. 4309169, TaqMan® One-Step RT-PCR Master Mix Reagents Kit and the ABI GeneAmp® 5700 Sequence Detection 
System were used here. All master mix calculation files automatically figure in safe extra preparative amounts so the user will not run short on final 
volumes or run into bubbles at the bottom of sample tubes. 
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Print Out One-Step Real-Time RT-PCR NRC Set-Up xtra ea.made Well size prepared: 30.00 uL
One-Step MM 2675.05 uL Set 1/sample 0.00 uL RNA added/well: 7.80 uL
30.00 uL prepared/Well WATER 133.75 uL Set 1/MM ea 0.00 uL Singlets 154 samples prepared
25.00 uL used/Well Total MMW prepared: 2808.81 uL Set 2/sample 0.00 uL 154 wells prepared
Total MMRT needed: 2614.50 uL Set 2/MM ea 0.00 uL Other
RIBO18S 194.31 uL RIBOS15
Fwd primer: 12.45 uL split Fwd primer: 249.00 uL split
Rev primer: 12.45 uL into Rev primer: 249.00 uL into
Probe: 12.45 uL 77 Probe: 37.35 uL 77
MMW: 1307.25 uL 22.20 uL amounts MMW: 1307.25 uL 22.20 uL amounts
Water: 498.00 uL then add 7.80 uL Water: 0.00 uL then add 7.80 uL
RNA to each RNA to each
xtra made
 
Fig. 34: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file (Sheet 2) which shows the automatically-calculated NRC master mix set-ups. ABI 
Cat. No. 4309169, TaqMan® One-Step RT-PCR Master Mix Reagents Kit and the ABI GeneAmp® 5700 Sequence Detection System were used here. Note 
that only housekeeper targets are tested for DNA contamination by NRC (no reverse transcription) analyses since they are the targets which will most 
likely reveal whether or not DNA contamination exists - given their endogenous genetic abundance in most samples. All master mix calculation files 
automatically figure in safe extra amounts so the user will not run short on final volumes or run into bubbles at the bottom of sample preparation tubes. 
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Fig. 35: Portion of FF2-6-001 set-up tool MasterEntrySheet.xls file (Sheet 2) which shows the user the amounts needed to make all the serial dilutions of 
Stock I which result in the simultaneous progressive creation of all optimally-calculated standard and ‘inter-plate calibrator’ (or extra standard) samples 
for all qPCR targets tested in any given study. 
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qPCR sample dynamic range of this set-up: 5 Sample post DNase 1: Inhibition Report
Accepted useful range of RNA in one-step 50,000 1 529 OK One-Step
real-time qPCR: 5 to 50000 pg/25 uL rxn 50 2 804 OK One-Step
We're at: 212.8 pg/25 uL well 500,000 3 681 OK One-Step
To: 13461.7 pg/25 uL well 4 272 OK One-Step
Stnd. Crv. Scope: 0.68 to 26923.5 pg/25 uL well 5 369 OK One-Step
0 samples with inhibition possibilities 6 421 OK One-Step
199.99 7 467 OK One-Step
Are you performing 2-Step? ("y" or "n"): n 8 577 OK One-Step
See also Tabatha IV for adjustments of these values 9 997 OK One-Step
aggressive RT? ("y" or "n"): y 10 475 OK One-Step
 If using cDNA instead of RNA in 2-step method Same DNase all 11 749 OK One-Step
TWO-STEP NOT IN USE Tabatha ("x"): 12 626 OK One-Step
            for all sample o.d.260nm readings x 13 544 OK One-Step
cDNA concentration adjust parameter: 1 14 314 OK One-Step
NOT USED µg total RNA/100 µL RT rxn 20 15 366 OK One-Step
            Two-Step well parameters: adjust ug 16 413 OK One-Step
Well-size prepared: NOT IN USE RNA/100 uL 17 522 OK One-Step
7.8 uL cDNA: NOT IN USE DNase rxn: 18 942 OK One-Step
Final used in-well: NOT IN USE 1 19 420 OK One-Step
500 uL Tabatha RNA spec. reading volume prepared 20 694 OK One-Step
10 uL RNA actual or theoretic part of that volume 21 571 OK One-Step
Tabatha: initial RNA vol. Group a Tabatha cDNA 200 uL 22 544 OK One-Step
made adj: 170 uL Group b Tabatha cDNA 200 uL 23 259 OK One-Step
Group c Tabatha cDNA 200 uL 24 311 OK One-Step
cDNA needed: Not in use Group d Tabatha cDNA 200 uL 25 358 OK One-Step
Group e Tabatha cDNA 200 uL 26 467 OK One-Step
Group f Tabatha cDNA 200 uL 27 887 OK One-Step
DNase conditions when all treatments are the same: 28 365 OK One-Step
10.00 uL 10X DNase Buffer 29 640 OK One-Step
0.00 uL nuclease-free Water 30 517 OK One-Step
20.00 uL DNase Enzyme (e.g. Turbo DNase) adj: 31 544 OK One-Step
70.00 uL RNA isolate 18 32 544 OK One-Step
10.00 uL Inactivation Reagent/Stop solution 33 257 OK One-Step
110.0 uL 34 303 OK One-Step
OK 35 413 OK One-Step
36 833 OK One-Step
ug/uL ng/uL 37 311 OK One-Step
Post RT: Not used Not used 38 585 OK One-Step
RT rxn. 1st Tier Target dilution 39 462 OK One-Step
1-step "x"
adj:
Tier 1 dilution info
ng/uL 
cDNA
 
Fig. 36: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file which informs the user of the qPCR dynamic range tested and whether or not 
inhibition can be expected of RNA samples during amplification. This is also the region where investigators tell the system whether two-step or one-step 
real-time qPCR is being performed. In two-step real-time qPCR applications, ten other Excel files are activated which all function to correctly handle cDNA 
preparation and its subsequent use in qPCR as managed by the FF2-6-001 qPCR set-up tool. These ten other files (known collectively as “Tabatha IV”) are 
not discussed in this manuscript. 
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Fig. 37: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file which shows the final volumes and relative dilutions achieved for all standards 
and inter-plate calibrators. Inter-plate calibrator samples serve an added function as additional standards since they are specifically diluted in each case 
to appear either between the first two points on each target’s 3- or 4-point standard curve or at any other place within each standard curve (as can all 
sample unknowns) by using the ‘sample aiming device’ shown in Figure 39. This helps to further define each standard curve and lends more credence to 
final quantitative analyses. Also shown here are the values one enters directly into the qPCR machine so it knows what serial progressive dilution factors 
are being used to create each different standard curve. 
 
 
Fig. 38: Portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file which shows the final in-well ng/µl total RNA concentrations achieved for each 
different qPCR target tested and how many picograms of total RNA are present in each final reaction well for each particular target. 
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Fig. 39: ‘Sample aiming device’ portion of FF2-6-001 qPCR set-up tool MasterEntrySheet.xls file which allows the investigator to manually pre-select 
where all qPCR signals will most likely appear within the respective Test Plate-determined LOG-linear standard curve ranges for each different target and 
housekeeper evaluated. 
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Fig. 40: Graph showing the result of LOG2 and LOG10 transformation of any data set (original values are shown as the top, dark blue line). For PCR of any 
variety, it is absolutely necessary to LOG transform the data in order to compress the variance so that relevant parametric and t-test analyses may ensue 
(29, 30). LOGx transformation of qPCR data also exposes the Monte-Carlo effect, e.g. low-copy number targets which amplify across threshold after 40 
cycles often exhibit statistically-unacceptable variance (2, 37). 
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Fig. 41: Graph showing the result of LOG2 transformation of a recent data set. Notice how the “zero” value on the x-axis ends up being where “control” or 
“calibrator” target expression appears. This is a very user-friendly way to represent final real-time qPCR data as it shows which samples are expressing 
targets above and below that of control or calibrator levels in a visually easy-to-interpret fashion (Olivier-Gallup-Ackermann, 2006 unpublished results). 
 
10 average Cts away from Genuine Signal 4.715 average Cts away from Genuine Signal
Genuine Signal Contaminating Target Signal Genuine Signal Contaminating Housekeeper Signal
Real-Time Stnd Curve Real-Time Stnd Curve Real-Time Stnd Curve Real-Time Stnd Curve
Target   m -3.32192809 Target   m -3.321928095 Housekeeper   m -3.351928095 Housekeeper   m -3.351928095
Target   b 23 Target   b 23 Housekeeper   b 16 Housekeeper   b 16
Efficiency: 100.00% Efficiency: 100.00% Efficiency: 98.76% Efficiency: 98.76%
UnkwnCts Rel. Qty UnkwnCts Rel. Qty Or:  Sample specific ∆Ct from ideal UnkwnCts Rel. Qty UnkwnCts Rel. Qty Or:  Sample specific ∆Ct from ideal
22 1.75 25 0.25 3 21 0.032230256 34 4.26537E-06 13
24.3 0.40453977 32.3 0.00158643 8 18.5 0.17807484 25.5 0.001464908 7
26 0.12499999 49 1.49012E-08 23 22 0.012112551 24 0.004105008 2
25 0.24804688 32 0.001953125 7 21.33 0.025689532 33.33 6.75836E-06 12
34 0.00048733 43 9.53674E-07 9 31 3.29506E-05 37 5.43187E-07 6
35 0.0002439 45 2.38419E-07 10 32 1.67136E-05 39 1.37492E-07 7
36 0.00012201 47 5.96046E-08 11 33 8.44317E-06 41 3.48022E-08 8
37 6.102E-05 49 1.49012E-08 12 34 4.25656E-06 43 8.80916E-09 9
38 3.0514E-05 51 3.72529E-09 13 35 2.14373E-06 45 2.22979E-09 10
39 1.5258E-05 53 9.31323E-10 14 36 1.07909E-06 47 5.64406E-10 11
40 7.6292E-06 55 2.32831E-10 15 37 5.43044E-07 49 1.42863E-10 12
41 2.861E-06 43 9.53674E-07 2 38 2.73247E-07 51 3.61617E-11 13  
Fig. 42: Depiction of the custom Excel file we use to examine the results of NRC plates to determine whether or not DNA contamination in RNA samples 
contributes significantly to sample target and/or housekeeper signals and, if they do, this file can be used to mathematically correct for it. Typically, 
signals elicited from NRC reactions that amplify across threshold greater than 5 cycles away from genuine qPCR signals have very little impact on final 
qPCR quantitation calculations. In our studies, NRC signals are typically 13 cycles or more away from genuine qPCR signals. 
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Fig. 43: Typical master mix reaction tube set-up illustrating the often extensive nature of hands-on real-time qPCR. Approximately 260 tubes containing 
optimally-diluted sample RNAs are not shown here. All tube set-ups were quickly defined by the FF2-6-001 qPCR set-up tool. 
 
 
Fig. 44: Typical storage of fluorogenic one-step real-time qPCR plates at 4°C before being run. In the example shown here, it took one person 42 hours to 
run all 14 plates back-to-back. Liquid-handling robot technology has been welcomed in many labs on account of the elaborate, time-consuming set-ups 
that frequently accompany truly interrogative qPCR. Electronic pipettes can be used otherwise to help shorten set-up time. 
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Fig. 45: Liquid handling robots represent a god-send to those who would normally set up all qPCR-related tubes and plates by hand. The Eppendorf 5070 
(shown) and 5075 (not shown) liquid-handling robots (A), BioTek’s PrecisionXSSilo (B), Tecan’s Freedom EVO® (C) and Beckman Coulter’s Biomek 3000 
(D) are all perfect for this application. In the absence of such technology, investigators are urged to at least employ the use of electronic/digital pipettes 
to make qPCR set-ups less demanding. 
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Fig. 46: Important example of how viral load in infected samples can be severely underestimated if qPCR inhibition is present but remains unaddressed. 
Imagine if the virus in this diagram were a deadly variety of H5N1. The parameters shown above we defined for hRSV using the FF2-6-001 qPCR set-up 
tool. 
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Fig. 47: Chart showing the advantage of using the CellsDirect™ One-Step RT-PCR Kit, Cat. No. 46-7201 product instead of conventional column-based 
RNA purification methods. This [new] product adheres to the “high throughput” philosophy of real-time qPCR by shortening the time it takes investigators 
to obtain qPCR-compatible cell lysates. Real-time qPCR inhibition is effectively eliminated from LCM-derived samples isolated using this method. 
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